KR101386442B1

KR101386442B1 - Process for Preparing Solid Microstructures by Blowing and Solid Microstructures Prepared by the Same

Info

Publication number: KR101386442B1
Application number: KR1020100030127A
Authority: KR
Inventors: 정형일; 김정동; 김미루; 이광; 정도현
Original assignee: 주식회사 라파스
Priority date: 2010-04-01
Filing date: 2010-04-01
Publication date: 2014-04-18
Also published as: KR20110110665A

Abstract

Microstructures and methods for their preparation are disclosed. According to the present invention, it is possible to produce solid microstructures having a diameter, sufficient effective length and hardness of micro-units, which can easily contain heat-sensitive drugs without denaturation or inactivation, and are simple, quick and inexpensive. Production costs can produce solid microstructures with the desired properties (eg, effective length, top diameter and hardness).

Description

Process for Preparing Solid Microstructures by Blowing and Solid Microstructures Prepared by the Same}

The present invention relates to a microstructure manufactured using a blowing method and a manufacturing method thereof, and more particularly, to a method of manufacturing a solid microstructure by a bottom-up and top-down lifting method using a blowing method and a solid micro manufactured by the same. It is about a structure.

Numerous drugs and treatments for the treatment of diseases have been developed, but in the delivery of drugs into the body, problems of passage through biological barriers (e.g., skin, oral mucosa and brain-vascular barrier) and drug delivery problems Remains to be improved.

The drug is generally orally administered in tablet form or capsule form, but can not be effectively delivered by the above-mentioned administration method only because a large number of drugs are digested or absorbed in the gastrointestinal tract or disappear by the mechanism of the liver. In addition, some drugs can not spread effectively through the intestinal mucosa. Compliance of the patient is also a problem (for example, in the case of a critical illiterate who can not take medication or at certain intervals).

Another common technique for drug delivery is through the use of conventional needles. While this method is more effective than oral administration, it has problems that cause pain at the injection site and local damage of the skin, hemorrhage, and infection at the injection site.

In order to solve the above problems, various microstructures including a microneedle have been developed. The microneedles developed so far have been mainly used for in vivo drug delivery, blood collection, and in-vivo analyte detection. Unlike conventional needles, the micro needle is characterized by non-painful skin penetration and non-trauma, and for painless skin penetration, the top diameter for minimum penetration is important. In addition, the microneedles are required to have sufficient physical hardness since they must penetrate the stratum corneum of 10-20 占 퐉, which is the most powerful obstacle in the skin. In addition, an appropriate length to increase the efficiency of drug delivery by reaching capillary blood vessels should also be considered.

After the conventional in-plane type microneedle (“Silicon-processed Microneedles”, Journal of microelectrochemical systems 8, 1999) has been proposed, various types of microneedles have been developed. The method of fabricating an out-of-plane solid microneedle (US Patent Application Publication No. 2002138049 “Microneedle devices and methods of manufacture and use thereof”) using an etching method is a solid silicon having a diameter of 50-100 μm and a length of 500 μm. By making microneedles, it was impossible to realize painless skin penetration, and it was difficult to deliver drugs and cosmetic ingredients to the target site.

Meanwhile, Prausnitz of the University of Georgia, USA, proposed a method of making biodegradable polymer microneedles by etching a glass or making a photolithography mold (Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery). , Journal of Controlled Release 104, 2005, 5166). In addition, in 2006, a method of manufacturing a biodegradable solid microneedle was proposed by mounting a material made in a capsule form at the end of a mold manufactured by a photolithography method (Polymer Microneedles for Controlled-Release Drug Delivery, Pharmaceutical Research 23, 2006, 1008). The use of this method has the advantage of being able to mount drugs that can be produced in the form of capsules, but since the hardness of the micro needle is weakened when the drug loading amount is increased, the application of the drug is limited to a drug requiring a large dose.

In 2005, absorbent microneedles were proposed by Nano Devices and Systems (Japanese Patent Application Laid-Open No. 2005154321; and “Sugar Micro Needles as Transdermic Drug Delivery System” , Biomedical Microdevices 7, 2005, 185). Such absorbable micro needles are intended for drug delivery or cosmetic use without removing the micro needles inserted into the skin. In this method, a composition in which maltose and drug are mixed is added to a mold and solidified to prepare a micro needle. The above-mentioned Japanese patent discloses that the micro needle is made into an absorbable type, and percutaneous absorption of the drug is proposed, but accompanied by pain upon penetration through the skin. Moreover, due to the technical limitations of mold making, it was not possible to produce microneedles having a length of 1 mm or more, which is the level required for effective drug delivery, with an appropriate top diameter with no pain.

Recently, biodegradable microneedles manufactured by Prausnitz, University of Georgia, USA, polyvinylpyrrolidone (PVP) and methacrylic acid in polydimethylsiloxane (PDMS) template : Minimal Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles, Advanced Materials 2008, 1). In addition, carboxymethyl cellulose was added to a pyramidal template to produce microneedles (Dissolving microneedles for transdermal drug delivery, Biomaterials 2007, 1). Despite the advantage of being able to make fast and easy fabrication using molds, it can not solve the limitation that it is difficult to fabricate by controlling the diameter and length of micro needle.

The skin consists of stratum corneum (<20 μm), epidermis (<100 μm), and dermis (300-2,500 μm) from the epidermis. Therefore, in order to deliver medicines and skin cosmetic ingredients without pain to a specific skin layer, it is necessary to manufacture the micro needle with a diameter of not more than 30 탆 at the upper end of the micro needle and an effective length of 200 to 2,000 탆, It is effective in delivering the ingredients. In order to deliver medicines or cosmetic ingredients through biodegradable solid micro needles, it is necessary to be able to exclude processes that can destroy the activity of drugs or cosmetic ingredients such as high temperature treatment and organic solvent treatment in the micro needle manufacturing process.

Conventional solid microneedles have been limited to materials such as silicon, polymers, metals, glass, etc. due to the limitations of the manufacturing method. It had a downside. Therefore, there is a need for a method of manufacturing microneedles capable of realizing painlessness when penetrating the skin and having a sufficient length to penetrate deeply into the skin and having sufficient hardness without particular limitation on the material and the need for such microneedles. Is continuing.

The present inventors have sought to develop a solid microstructure which has a micro-unit diameter, sufficient effective length and hardness, and can easily contain heat-sensitive drugs without modification or inactivation. As a result, the present inventors have developed a novel method for producing solid microstructures having the above advantages, including the lifting, blowing and solidification of viscous materials, which results in a simpler, faster and lower cost of production. The present invention has been completed by confirming that solid microstructures having properties (eg, effective length, top diameter and hardness) can be produced.

Accordingly, it is an object of the present invention to provide a method for producing a solid microstructure.

Another object of the present invention is to provide a solid microstructure.

Other objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.

According to one aspect of the invention, the invention provides a method of making a solid microstructure comprising the following steps:

(a) preparing a viscous composition on a substrate;

(b) contacting the contact projection of the lifting support with the viscous composition;

(c) blowing the viscous composition to condensation and solidification of the viscous composition; And

(d) cutting the resultant of step (c) to form a solid microstructure.

The inventors have sought to develop solid microstructures having a diameter, sufficient effective length and hardness of micro units and which can easily contain heat sensitive drugs without denaturation or inactivation. As a result, the present inventors have developed a novel method for producing solid microstructures having the above advantages, including the lifting, blowing and solidification of viscous materials, which results in a simpler, faster and lower cost of production. It has been found that solid microstructures with properties (eg, effective length, top diameter and hardness) can be produced.

The method of the present invention basically produces a solid microstructure using blowing. Thus, the method of the present invention is named Blowing-prepared Solid Microstructures (BSM).

The method of the invention is also named according to the direction of movement of the lifting support, i.e., bottom-up if the movement of the support is upwards and top-down if downward. Bottom-up is abbreviated as Blowing-prepared Solid Microstructures with Upward Movement (BSM-UM).

On the other hand, the BSM-UM and BSM-DM of the present invention are classified according to the movement of the lifting support, but instead of the lifting support, the substrate may move to impart this direction.

Preferred embodiments of the bottom-up manufacturing method of the present invention include the following steps:

(a) applying a viscous composition on a substrate to form a base structure, and then spotting the viscous composition on the base structure to prepare a viscous composition on the substrate;

(b) contacting the contacting projection of the lifting support with the spotted viscous composition;

(d) cutting the resultant of step (c) to form a solid microstructure.

Preferred embodiments of the top-down manufacturing method of the present invention include the following steps:

(a) contacting the viscous composition by (i) inserting the contact projection of the lifting support into the opening of the substrate coated with the viscous composition, or (ii) inserting the contact projection of the lifting support into the opening of the substrate not coated with the viscous composition. Then contacting the viscous composition with the contact projection of the lifting support by applying the viscous composition to the opening of the substrate or the entire substrate;

(b) condensing and solidifying the viscous composition by blowing on the viscous composition and lowering the contact protrusion or by lowering the contact protrusion and then blowing on the viscous composition; And

(c) cutting the resultant of step (b) to form a solid microstructure.

The method of the present invention will be described in detail in accordance with the respective steps.

Step (a): Preparation of a viscous composition on a substrate

The materials used in the present invention to make microstructures are viscous compositions. As used herein, the term viscous composition refers to a composition having the ability to be lifted upon contact with a lifting support used in the present invention to form a microstructure.

The viscosity of the viscous composition can be variously changed according to the kind, concentration, temperature or addition of a thickener included in the composition, and can be adjusted to suit the purpose of the present invention. The viscosity of the viscous composition can be controlled by the inherent viscosity of the viscous material and can also be controlled by using additional viscosity modifying agents in the viscous composition.

For example, thickeners commonly used in the art such as hyaluronic acid and salts thereof, polyvinylpyrrolidone, cellulose polymers, dextran, gelatin, glycerin, polyethyleneglycol, polysorbate, propylene glycol, Povidone, carbomer, gum ghatti, guar gum, glucomannan, glucosamine, dammer resin, rennet casein, locust bean gum, microfibrillated cellulose ), Psyllium seed gum, xanthan gum, arabino galactan, arabian gum, alginic acid, gelatin, gellan gum, carrageenan, karaya gum, curdlan ( curdlan, chitosan, chitin, tara gum, tamarind gum, tragacanth gum, furcelleran, pectin or pullulan Thickener of Solid Microstructures Component, for example, the viscosity and added to a composition comprising a biocompatible material can be suitably adjusted to the invention. Preferably, the viscous composition used in the present invention has a viscosity of 200000 cSt or less.

According to a preferred embodiment of the present invention, the viscous composition used in the present invention comprises a biocompatible or biodegradable material. As used herein, the term biocompatible material means a material that is substantially nontoxic to the human body, chemically inert and immunogenic. As used herein, the term biodegradable material means a material that can be degraded by body fluids or microorganisms in a living body.

Preferably, the viscous composition used in the present invention is selected from the group consisting of hyaluronic acid and salts thereof, polyvinylpyrrolidone, cellulose polymer, dextran, gelatin, glycerin, polyethylene glycol, polysorbate, propylene glycol, povidone, But are not limited to, carbomer, gum ghatti, guar gum, glucomannan, glucosamine, dammer resin, rennet casein, locust bean gum, microfibrillated cellulose, Such as psyllium seed gum, xanthan gum, arabino galactan, gum arabic, alginic acid, gelatin, gellan gum, carrageenan, karaya gum, curdlan, , Chitosan, chitin, tara gum, tamarind gum, tragacanth gum, furcelleran, pectin or pullulan. More preferably, the viscous substance contained in the viscous composition used in the present invention is a cellulose polymer, more preferably hydroxypropylmethylcellulose, hydroxyalkylcellulose (preferably hydroxyethylcellulose or hydroxypropylcellulose ), Ethylhydroxyethylcellulose, alkylcellulose and carboxymethylcellulose, even more preferably hydroxypropylmethylcellulose or carboxymethylcellulose, and most preferably carboxymethylcellulose.

Alternatively, the viscous composition may comprise a biocompatible and / or biodegradable material as a major component.

Biocompatible and / or biodegradable materials that can be used in the present invention are, for example, polyesters, polyhydroxyalkanoates (PHAs), poly (α-hydroxyacid), poly (β-hydroxyliquid solutions). Seed), poly (3-hydrosuccinate-co-valorate; PHBV), poly (3-hydroxyproprionate; PHP), poly (3-hydroxyhexanoate; PHH), poly (4- Hydroxyacid), poly (4-hydroxybutyrate), poly (4-hydroxy valerate), poly (4-hydroxyhexanoate), poly (esteramide), polycaprolactone, polylactide, Polyglycolide, poly (lactide-co-glycolide; PLGA), polydioxanone, polyorthoester, polyetherester, polyanhydride, poly (glycolic acid-co-trimethylene carbonate), polyphospho Ester, Polyphosphoester Urethane, Poly (Amino Acid), Poly Yarn Anoacrylate, poly (trimethylene carbonate), poly (iminocarbonate), poly (tyrosine carbonate), polycarbonate, poly (tyrosine arylate), polyalkylene oxalate, polyphosphazene, PHA-PEG, ethylene Vinyl alcohol copolymers (EVOH), polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, styrene-isobutylene-styrene triblock copolymers, acrylic polymers and copolymers, vinyl halides Polymers and copolymers, polyvinyl chloride, polyvinyl ether, polyvinyl methyl ether, polyvinylidene halides, polyvinylidene fluoride, polyvinylidene chloride, polyfluoroalkenes, polyperfluoroalkenes, polyacrylonitrile, Polyvinyl ketone, polyvinyl aromatics, polystyrene, polyvinyl ester, polyvinyl acetate, ethyl Ethylene-methyl methacrylate copolymer, acrylonitrile-styrene copolymer, ABS resin and ethylene-vinyl acetate copolymer, polyamide, alkyd resin, polyoxymethylene, polyimide, polyether, polyacrylate, polymethacryl Latex, polyacrylic acid-co-maleic acid, chitosan, dextran, cellulose, heparin, hyaluronic acid, alginate, inulin, starch or glycogen, preferably polyester, polyhydroxyalkanoate (PHAs), poly ( α-hydroxyacid), poly (β-hydroxyacid), poly (3-hydrosuccibutyrate-co-valorate; PHBV), poly (3-hydroxypropionate; PHP), poly (3-hydroxyhexanoate; PHH), poly (4-hydroxyacid), poly (4-hydroxybutyrate), poly (4-hydroxyvalorate), poly (4-hydroxyhexanoate), poly (esteramide), polycaprolactone, polylactide, polyglycolide, poly (lactide-co-glycolide; PLGA) , Polydioxanone, polyorthoester, polyether ester, polyanhydride, poly (glycolic acid-co-trimethylene carbonate), polyphosphoester, polyphosphoester urethane, poly (amino acid), polycyano Acrylate, poly (trimethylene carbonate), poly (iminocarbonate), poly (tyrosine carbonate), polycarbonate, poly (tyrosine arylate), polyalkylene oxalate, polyphosphazene, PHA-PEG, chitosan, Dextran, cellulose Is heparin, hyaluronic acid, alginate, inulin, starch or glycogen.

According to a preferred embodiment of the present invention, the viscous composition used in the present invention is dissolved in a suitable solvent to exhibit a viscosity. On the other hand, some of the materials exhibiting viscosity exhibits viscosity when melted by heat. In order to maximize the advantage of the non-thermal process, one of the advantages of the present invention, the material used in the viscous composition is viscous when dissolved in a suitable solvent.

The solvent used to prepare the viscous composition by dissolving the viscous material is not particularly limited, and may be water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, 1,3-butylene glycol, hexane , Diethyl ether or butyl acetate may be used as the solvent, preferably water or lower alcohol, most preferably water.

The substrate containing the viscous composition is not particularly limited and may be made of, for example, a polymer, an organic chemical, a metal, a ceramic, a semiconductor, or the like.

According to a preferred embodiment of the present invention, the viscous composition additionally comprises a drug. One of the main uses of the microstructures of the present invention is microneedle, which is intended for transdermal administration. Therefore, in the process of preparing the viscous composition is prepared by mixing the drug with the biocompatible material.

Drugs that can be used in the present invention are not particularly limited. For example, the drug includes chemical drugs, protein drugs, peptide drugs, nucleic acid molecules for gene therapy, and nanoparticles.

Drugs that can be used in the present invention include, for example, anti-inflammatory drugs, analgesics, anti-arthritis agents, antispasmodics, antidepressants, antipsychotics, neurostabilizers, anti-anxiety agents, antagonists, antiparkin disease drugs, cholinergic agonists, anticancer agents, Antiangiogenic, immunosuppressive, antiviral, antibiotic, appetite suppressant, analgesic, anticholinergic, antihistamine, antimigraine, hormonal, coronary, cerebrovascular or peripheral vasodilator, contraceptive, antithrombotic, diuretic, anti Hypertension, cardiovascular disease treatment agents, cosmetic ingredients (eg, anti-wrinkle agents, skin aging inhibitors and skin lightening agents) and the like, but are not limited thereto.

According to a preferred embodiment of the present invention, the manufacturing process of the microstructure according to the present invention is performed under non-heating treatment. Therefore, even if the drug used in the present invention is a drug that is heat-sensitive such as protein medicine, peptide medicine, gene therapy nucleic acid molecule, etc., according to the present invention, it is possible to manufacture a microstructure containing the drug.

According to a preferred embodiment of the present invention, the method of the present invention is used for the production of micro-structures containing heat-sensitive drugs, more preferably protein drugs, peptide drugs or vitamins (preferably vitamin C).

The protein / peptide medicament contained in the microstructures by the method of the present invention is not particularly limited and includes hormones, hormone analogs, enzymes, inhibitors, signaling proteins or parts thereof, antibodies or parts thereof, single chain antibodies, binding proteins or Its binding domains, antigens, adhesion proteins, structural proteins, regulatory proteins, toxin proteins, cytokines, transcriptional regulators, blood coagulation factors and vaccines, and the like. More specifically, the protein / peptide medicament includes insulin, insulin-like growth factor 1 (IGF-1), growth hormone, erythropoietin, granulocyte-colony stimulating factors (G-CSFs), and GM-CSFs (granulocytes). / macrophage-colony stimulating factors, interferon alpha, interferon beta, interferon gamma, interleukin-1 alpha and beta, interleukin-3, interleukin-4, interleukin-6, interleukin-2, epidermal growth factors (EGGFs), calcitonin ), Adrenocorticotropic hormone (ACTH), tumor necrosis factor (TNF), atobisban, buserelin, cetrorelix, deslorelin, desmopressin ), Dynorphin A (1-13), elcatonin, eleidosin, eptifibatide, growth hormone releasing hormone-II (GHRH-II), gonadore Gonadorelin, goserelin, hystrelin, leuprorelin, lifelessin ( lypressin, octreotide, oxytocin, phytocin, pitressin, secretin, sincalide, terlipressin, thymopentin, thymosine ) α1, triptorelin, bivalirudin, carbetocin, cyclosporin, exedine, lanreotide, LHRH (luteinizing hormone-releasing hormone), na Naparin, parathyroid hormone, pramlintide, T-20 (enfuvirtide), thymalfasin and ziconotide.

According to a preferred embodiment of the present invention, the viscous composition additionally comprises energy. In this case, the microstructure may be used for transmitting or transmitting energy forms such as thermal energy, light energy, and electrical energy. For example, in photodynamic therapy, microstructures can be used to direct light to specific areas within the body, such that light can act directly on tissues or light can act on mediators such as light-sensitive molecules. Can be used to derive.

The substrate for receiving the viscous composition is not particularly limited and may be made of materials such as polymers, organic chemicals, metals, ceramics, semiconductors, and the like.

According to a preferred embodiment of the present invention for producing a solid microstructure for multidrug release, the viscous composition comprises the steps of: (a-1) preparing a viscous biocompatible / biodegradable material as a backbone of the microstructure; (a-2) prepared by mixing the biocompatible / biodegradable material and the drug of (a-1), wherein the drug is incorporated into a microparticle, nanoparticle or emulsion formulation.

When the method of the present invention is carried out in the bottom-up manner described above (BSM-UM method), preferably step (a) is applied to the substrate to form a base structure by applying a viscous composition onto the base structure Spot the viscous composition.

Step (b): contacting the contact projection of the lifting support to the viscous composition

Then, the contact projection of the lifting support is brought into contact with the viscous composition. In order to prepare a microstructure using the viscosity, which is a characteristic of a viscous composition, the lifting support must first be lowered to contact the viscous composition.

One specific embodiment of the lifting support is illustrated in FIG. 1. The lifting support includes one or more contacting protrusions, and a viscous composition including, for example, a biocompatible material is attached to the contacting protrusions (see FIG. 2B). According to a preferred embodiment of the present invention, the contact protrusion in the lifting support is patterned (see FIGS. 1 and 2). Such patterning is advantageous when fabricating the microstructures of the present invention in patches and may be fabricated in the form of an array containing various drugs for each microstructure or some microstructures (see FIG. 3).

According to a preferred embodiment of the present invention, the viscous composition is contacted to the contact projections of the lifting support and then blown, so that the viscous composition attached to the contact projections can be easily condensed to generate microstructures from the contact projections to the substrate. (See step (c)). The way of blowing can be done in various ways. Most preferably, blowing is carried out through one or more blowing holes formed in the lifting support. When blowing to the viscous composition through the tuyere, the volume of the viscous composition is first reduced from the periphery of the viscous composition attached to the contact projection, thereby forming a microstructure based on the contact projection.

When the method of the present invention is carried out in the bottom-up manner described above (BSM-UM method), preferably step (b) is made by contacting the contact projection of the lifting support with the viscous composition spotted on the base structure. Conduct.

When the method of the present invention is carried out in the above-mentioned top-down manner (BSM-DM method), preferably, the substrate has a hole and the steps (a) and (b) are (i) a substrate coated with a viscous composition. Contacting the viscous composition by inserting the contact projection of the lifting support into the opening of the substrate, or (ii) inserting the contact projection of the lifting support into the opening of the substrate to which the viscous composition has not been applied, and then adding the viscous composition to the opening of the substrate or the entire substrate. The coating is carried out by contacting the viscous composition with the contact projection of the lifting support.

Step (c): Condensation and solidification of the viscous composition by blowing

One of the greatest features of the present invention is the manufacture of microstructures by blowing into a viscous composition to condense and solidify the viscous composition. As used herein, the term condensation means that the volume decreases in comparison with the initial volume during the solidification of the viscous material in the fluid state.

In general, in order to manufacture a microstructure, a viscous composition is drawn beyond the effective length of the microstructure. In contrast, the present invention utilizes the condensation properties of the viscous composition to provide the final microstructure, the full effective length of the microstructure being formed by blowing. That is, in the process of condensation and solidification of the viscous composition to form the microstructure attached to the lifting support by blowing, the viscous composition of the viscous composition attached to the contact projection is wide and the lower part around the attached part Coagulation proceeds faster than the composition to form an intermediate structure in which a viscous composition at the bottom of the intermediate structure is concentrated and condensed on the intermediate structure. As a result, microstructures having an effective length and a skin penetrable hardness or more are formed around the intermediate structure (see FIGS. 2 d and e).

According to a preferred embodiment of the present invention, the method further includes the step (b-2) of lifting the lifting support between the steps (b) and (c). Although the present invention can produce a microstructure without lifting the lifting support, the shape of the microstructure can be variously manufactured as desired by lifting the lifting support. As used herein, the term lifting means pulling up using the viscosity or adhesion of the viscous composition. According to a more preferred embodiment of the invention, the length of the intermediate structure formed by the lifting is smaller than the length of the finally produced microstructure, even more preferably from 1/100 to 80 of the length of the finally produced microstructure. / 100, most preferably 5/100 to 70/100 height.

The microstructure having an effective length can be manufactured despite lifting to a height lower than the length of the finally produced microstructure, because the viscous composition is condensed and solidified around the intermediate structure when blowing to the viscous composition.

Lifting speed and time are not particularly limited. Preferably, the lifting rate is 1-50 μm / s, more preferably 3-30 μm / s, and the lifting time is preferably 10-600 seconds, more preferably 20-300 seconds, even more preferably Is 30-200 seconds.

Condensation and solidification of the viscous composition uses a blowing method, the blowing may be made in a variety of ways. According to a preferred embodiment of the present invention, the blowing is carried out through one or more tuyeres included in the lifting support used in the present invention. Alternatively, the blowing may be performed by blowing directly to the viscous composition or simultaneously with blowing through the lifting support, without passing through the lifting support. Blowing through the tuyeres of the lifting support is advantageous in terms of uniform blowing and also for the formation of microstructures having a non-distorted shape.

Blowing for producing the microstructures can be induced in a variety of ways. If it uses the characteristics of the lifting and the properties of condensation and solidification of the viscous composition, the manner of blowing is not particularly limited. Three exemplary preferred embodiments are described below:

According to the first embodiment, the blowing is carried out simultaneously with the lifting of step (b-2). Even after the lifting is completed, the blowing is continuously performed to finally generate the microstructure.

According to a second embodiment, the blowing is carried out after the lifting of step (b-2).

According to a third embodiment, the blowing is performed alternately alternately with the lifting of step (b-2). In this case, the lifting and blowing are alternately made over several steps, and may be carried out in various stages depending on the properties such as viscosity and solidification rate of the viscous composition until the whole lifting is completed. According to this embodiment, condensation and solidification alternate with lifting until the entire lifting of the lifting support is completed.

According to a preferred embodiment of the present invention, the blowing is carried out according to the first or second manner described above.

In the case where the method of the present invention is carried out in the above-described top-down manner (BSM-DM method), preferably step (c) blows the viscous composition and lowers the contacting projections to condense and solidify the viscous composition. Do it.

Step (d): Formation of Final Microstructures by Cutting

In the result of step (c), the site containing the effective length of the microstructure is cut to finally obtain the microstructure. Cutting can be carried out in various ways, for example, by physical cutting or laser cutting. As described in the examples below, cutting at a higher lifting speed can yield microstructures of the desired effective length.

The present invention can provide a variety of microstructures, preferably the microstructures provided by the present invention are microneedle, microblade, microknife, microfiber, microspike, microprobe, microbarb, microarray Or a microelectrode, more preferably microneedle, microblade, microknife, microfiber, microspike, microprobe or microvalve, most preferably solid microneedle.

According to a preferred embodiment of the present invention, the microstructures of the present invention have a top diameter of 1-500 μm, more preferably 2-300 μm, most preferably 5-100 μm, and preferably an effective length. 100-10,000 μm, more preferably 200-10,000 μm, even more preferably 300-8,000 μm, most preferably 500-2,000 μm.

As used herein, the term upper end of a microstructure refers to one end of the microstructure having the smallest diameter. As used herein, the term effective length means the vertical length from the top of the microstructure to the support surface. As used herein, the term solid microneedles means microneedles made integrally without forming hollows.

The diameter, length and / or shape of the microstructures can be controlled by varying the diameter of the lifting support contact projections, the strength of the blowing or the viscosity of the viscous composition.

(d) cutting the resultant of step (c) to form a solid microstructure.

The BSM-UM method of the present invention will be described in detail according to each step as follows:

Step (a): application of the viscous composition on the substrate, spotting the viscous composition and forming the base structure

In the present invention, the step (a) is a drug spotting immediately after the application of the viscous composition, the viscous composition without the application of the viscous composition immediately after spotting or spotting the viscous composition without the application of the viscous composition, after the base is generated, the drug is included Spotting the viscous composition is included. Preferably, the step (a) in the present invention includes applying a viscous composition, spotting the viscous composition and forming a base structure on the substrate.

The material used in the present invention to prepare microstructures is a viscous composition. As used herein, the term "viscosity composition" refers to a composition having the ability to be lifted upon contact with a lifting support used in the present invention to form a microstructure.

The viscosity of the viscous composition can be variously changed according to the kind, concentration, temperature or addition of a thickener included in the composition, and can be adjusted to suit the purpose of the present invention. The viscosity of the viscous composition can be controlled by the inherent viscosity of the viscous material and can also be controlled by using additional viscosity modifying agents in the viscous composition. Preferably, the viscous composition used in the present invention has a viscosity of 200000 cSt or less.

According to a preferred embodiment of the present invention, the viscous composition used in the present invention includes a biocompatible or biodegradable material. As used herein, the term “biocompatible material” means a material that is substantially nontoxic to the human body, chemically inert and immunogenic. As used herein, the term "biodegradable material" refers to a material that can be degraded by body fluids or microorganisms in a living body.

According to a preferred embodiment of the present invention, the viscous composition used in the present invention is dissolved in a suitable solvent to exhibit a viscosity. On the other hand, some of the materials exhibiting viscosity exhibits viscosity when melted by heat. In order to maximize the advantage of the non-heating process, one of the advantages of the present invention, the material used in the viscous composition is viscous when dissolved in a suitable solvent.

Drugs that can be used in the present invention are not particularly limited. For example, the drug may include, but is not limited to, chemicals, protein drugs, peptide drugs, nucleic acid molecules for gene therapy, and nanoparticle cosmetic ingredients (eg, anti-wrinkle agents, skin aging inhibitors, and skin lightening agents).

According to a preferred embodiment of the present invention, the manufacturing process of the microstructure according to the present invention is carried out under non-heating treatment. Therefore, even if the drug used in the present invention is a heat sensitive drug such as a protein medicine, a peptide medicine, a gene therapy nucleic acid molecule, etc., according to the present invention, it is possible to manufacture a microstructure containing the drug.

In order to prepare a viscous composition on a substrate, first, by applying a viscous composition on a substrate and drying (a-b of FIG. 3), a base structure made of a viscous composition by spotting the viscous composition at a position where a microstructure is to be manufactured using a dispenser. The manufacturing step is performed (c-d of FIG. 3). The diameter of the base structure can be adjusted by the amount of viscous composition spotted, taking into account the spacing between the microstructures. In addition, the height of the base structure can be adjusted according to the number of spottings (increase spotting 70 ~ 150 ㎛). Since this process may be performed discontinuously with other manufacturing processes, it is possible to prepare a viscous composition on a substrate in advance according to the quantity to be produced.

Spotting the viscous composition containing the drug on the base structure using a dispenser on the prepared substrate (Fig. 3e).

According to a preferred embodiment of the present invention, during the process of applying the viscous composition on the substrate or on the substrate by applying a viscous composition, by spotting the viscous composition to dry by blowing air to form a base structure (base structure) Let's do it.

According to a preferred embodiment of the present invention, during the process of spotting the viscous composition on the base structure or after spotting the viscous composition on the base structure is blown to the spotted viscous composition.

According to a preferred embodiment of the invention, the spotted viscous composition comprises a drug.

According to a preferred embodiment of the present invention for producing a solid microstructure for multidrug release, the viscous composition to be spotted comprises the steps of: (a-1) preparing a viscous biocompatible / biodegradable substance as the backbone of the microstructure; (a-2) prepared by mixing the biocompatible / biodegradable material and the drug of (a-1), wherein the drug is incorporated into a microparticle, nanoparticle or emulsion formulation.

Step (b): contacting contact of the lifting support to the spotted viscous composition

The contact protrusion of the lifting support is contacted with the spotted viscous composition (FIG. 3 f). In order to manufacture a microstructure using viscosity, which is a characteristic of a viscous composition, the lifting support must first be lowered to contact the viscous composition. At this time, it is possible to change the diameter of the upper end of the final microstructure according to the diameter of the contact projection. As the diameter of the contact protrusion increases, the diameter of the upper end of the microstructure increases, and as the diameter of the contact protrusion decreases, the diameter of the upper end of the microstructure tends to decrease. Preferably, using a contact protrusion having a diameter of 50 to 500 µm is easy for the production of a microstructure effective for skin penetration.

Specific examples of lifting supports are shown in FIG. 2. The lifting support includes one or more contacting protrusions, and a viscous composition including, for example, a biocompatible material is attached to the contacting protrusions. According to a preferred embodiment of the present invention, the contact protrusion in the lifting support is patterned. Such patterning is advantageous when fabricating the microstructures of the present invention in patches and may be fabricated in the form of an array containing various drugs for each microstructure or some microstructures.

In addition, the amount of drug-containing viscosities spotted can control the length and diameter limits of the fabricated microstructures. For example, when the amount of the drug-containing viscous composition is less than 1 μL, it is difficult to manufacture a microstructure having a length of 800 μm or more and a diameter of 100 μm or more, and therefore, to produce a microstructure having a longer and thick effective length, the drug-containing viscous composition is required. More spotting needs to be done.

Step (c): solidification of the viscous composition by blowing in the viscous composition and lifting the contact projections to the desired effective length.

One of the greatest features of the present invention is the manufacture of microstructures by blowing into a viscous composition to solidify the viscous composition. As used herein, the term “coagulation” is a process of solidifying a viscous material in a fluid state, and as the solidification proceeds, the volume decreases compared with the initial volume.

The present invention utilizes the condensation properties of the viscous composition to provide the final microstructure, the full effective length of the microstructure being formed by blowing. That is, in the process of solidifying the viscous composition to form the microstructure attached to the lifting support by blowing, the air exposure area of the viscous composition attached to the contact projection is wider than that of the viscous composition near the attached part. The solidification proceeds rapidly to form an intermediate structure, and the viscous composition at the bottom of the intermediate structure concentrates on the intermediate structure. As a result, microstructures having an effective length and a skin penetrable hardness or greater are formed around the intermediate structure (g-h of FIG. 3).

According to a preferred embodiment of the present invention, the method further comprises the step of lifting the lifting support before and during the blowing. Although the present invention can produce a microstructure without lifting the lifting support, the shape of the microstructure can be variously manufactured by lifting the lifting support. As used herein, the term “lifting” means pulling up or down using the viscosity or adhesion of a viscous composition. According to a more preferred embodiment of the invention, the length of the intermediate structure formed by the lifting is smaller than the length of the finally produced microstructure, even more preferably from 1/100 to 80 of the length of the finally produced microstructure. / 100, most preferably 10/100 to 70/100 height.

Despite the lifting to a height lower than the length of the finally produced microstructure, the effective length of the microstructure can be produced because the viscous composition solidifies around the intermediate structure when blowing to the viscous composition.

The step of lifting is to pull up the drug-containing viscous composition through the primary lifting (3 to 20 μm / s, 5 to 15 seconds), to make the viscous composition and the lifting support firm, and the second lifting (5 to 50 μm / s, 5 to 60 seconds) to form the structure up to the desired length.

Looking in detail at the lifting step, if the lifting (3 ~ 20 ㎛ / s, 5 ~ 15 seconds) in the primary lifting without blowing, the viscous composition is connected to the support without fast solidifying the intermediate structure of the small diameter form Form. Then, when the support is pulled up to a desired length through the secondary lifting while blowing, the viscous composition is gathered to the lower end of the microstructure by the cohesive force between the viscous compositions, and solidification by blowing occurs. As a result, it is possible to manufacture a microstructure capable of skin permeation having a top diameter of 5 to 30 μm, which is easy for skin penetration through primary lifting, and a bottom part of 100 to 500 μm through blowing and secondary lifting. If the air is blown from the primary lifting, it is difficult to manufacture a microstructure having a diameter within 30 μm that is easy for skin penetration.

The coagulation of the viscous composition uses a blowing method, the blowing may be made in a variety of ways. Blowing is made toward the direction in which the microstructures are made and may be made in a symmetrical direction, such as two directions and four directions. In addition, the blowing may be carried out through one or more blowholes (refer to FIG. 1) included in the lifting support used in the present invention, or may be carried out by directly blowing the viscous composition or simultaneously blowing through the lifting support. It is not limited to this.

FIG. 13 is a diagram illustrating a case where a microstructure is manufactured without a blowing process. Without blowing, the coagulation of the viscous material is not induced quickly, so even after the viscous composition and the lifting support are in contact with each other, most of the viscous material is returned to the substrate by the cohesion and gravity of each other, thus disconnecting the lifting support and forming a microstructure. Could not.

In addition, lifting speed is an important factor in determining the desired properties of the microstructures (eg, effective length, top diameter and hardness). When fabricating the same length microstructure at the same blowing speed, it was confirmed that the faster the lifting speed, the smaller the diameter of the upper end of the microstructure. In addition, when fabricating a microstructure of the same length at the same lifting speed, it was confirmed that the faster the blowing speed, the larger the diameter of the upper end of the microstructure.

14 is a graph showing the change in diameter of the microstructure according to the lifting speed, the diameter change of the microstructure according to the wind speed. The type and viscosity of the viscous substance, the inner diameter of the contact protrusion (500 ㎛), the final length (800 ㎛) of the microstructure to be manufactured and the like all remained the same.

In the bottom-up manufacturing method, the bottom of the microstructure having a length of 1 mm or less is about 40% of the base diameter from the bottom to about 30% in the direction of the top, and is manufactured in a thick form to maintain the force even when the top is thin. To perform. Afterwards, the diameter continues to decrease toward the top end, and at the top end, the diameter decreases within 10% of the base diameter (FIG. 20). The thinning of the upper end of the microstructure is tapered by the effect of the primary lifting lifting at high speed without blowing, and the relatively thick of the lower end is made by the effect of the secondary lifting slowly lifting with the blowing. In this manner, a microphone structure having a structure that satisfies strength and diameter suitable for skin penetration is simultaneously produced.

From the lower end of the microstructure having a length of 1 to 2 mm to about 15% from the upper end, it is about 40% of the diameter of the base and is made thick to maintain the force even when the upper end is thin. Afterwards, the diameter continues to decrease toward the upper end and decreases to within 5% of the base diameter at the upper end (FIG. 20). The thinning of the upper end of the microstructure is tapered by the effect of the primary lifting lifting at high speed without blowing, and the relatively thick of the lower end is made by the effect of the secondary lifting slowly lifting with the blowing. In this manner, a microphone structure having a structure that satisfies strength and diameter suitable for skin penetration is simultaneously produced.

From the lower end of the microstructure having a length of 2 mm or more to about 10% in the direction of the upper end is small as about 40% of the diameter of the base and is made in a thick form to maintain the force even if the upper end is thin. Afterwards, the diameter continues to decrease toward the top end and within 4% of the base diameter at the top end (FIG. 20). The thinning of the upper end of the microstructure is tapered by the effect of the primary lifting lifting at high speed without blowing, and the relatively thick of the lower end is made by the effect of the secondary lifting slowly lifting with the blowing. In this manner, a microphone structure having a structure that satisfies strength and diameter suitable for skin penetration is simultaneously produced.

In order to produce an optimized microstructure (eg, effective length, top diameter and hardness), optimization of lifting speed, blowing speed, and the like is required.

In the above experiments, the length of the microstructure was made constant to 800 μm in order to see the change of the diameter of the upper end of the microstructure according to the wind speed and the lifting speed of the support, but the microstructure was optimized to change the lifting speed according to the length of the microstructure. It is an important factor in production.

According to a preferred embodiment of the present invention, the blowing in step (c) is carried out while lifting the lifting support, or after the lifting is completed, or the blowing and lifting are performed discontinuously alternately.

According to a preferred embodiment of the present invention, the blowing in step (c) is carried out after the first lifting is completed and then the blowing is carried out simultaneously with the second lifting.

Step (d): Formation of Final Microstructures by Cutting

In the result of step (c), the site including the effective length of the microstructure is cut to finally obtain the microstructure (h of FIG. 7). Cutting can be carried out in various ways, for example, by physical cutting or laser cutting. It is preferable to cut at a high speed so as to cut apart from the lifting structure at the portion having the smallest diameter physically.

According to a preferred embodiment of the present invention, the microstructures of the present invention have a top diameter of 1-500 μm, more preferably 2-300 μm, most preferably 5-80 μm, and preferably an effective length. 100-10,000 μm, more preferably 100-8,000 μm, even more preferably 200-5,000 μm, most preferably 200-3,000 μm.

As used herein, the term "top end" of a microstructure refers to the distal end of the microstructure having the smallest diameter. As used herein, the term “effective length” means the vertical length from the top of the microstructure to the support surface. As used herein, the term “solid microneedles” refers to microneedles made integrally without forming hollows.

The diameter, length and / or shape of the microstructures can be controlled by varying the diameter of the lifting support contact projections, the blowing strength or the viscosity of the viscous composition.

Preferred embodiments of the top-down manufacturing method (BSM-DM method) of the present invention include the following steps:

(c) cutting the resultant of step (b) to form a solid microstructure.

The present inventors have tried to develop a solid microstructure having a uniform shape without interference between each structure in the fabrication of an array type microstructure by using a top-down lifting method and having a diameter, sufficient effective length and hardness in micro units. As a result, the present inventors have developed a novel method for producing solid microstructures having the above advantages, including a top-down lifting, blowing and solidification process of viscous materials, which results in a simpler, faster and lower cost of production. It has been found that solid microstructures can be produced with desired properties (eg, effective length, top diameter and hardness).

The BSM-DM method of the present invention will be described in detail with each step as follows:

Step (a): preparation of the viscous composition and contact of the viscous composition with the contact projection of the lifting support

The contact projection of the lifting support is inserted into the opening of the substrate to which the viscous composition is applied to contact the viscous composition, or the contact protrusion of the lifting support is inserted to the opening of the substrate to which the viscous composition is not applied, and then the viscous composition is opened to the substrate or The contact projection of the lifting support is brought into contact with the viscous composition by coating the entire substrate.

According to a preferred embodiment of the invention, the viscous composition contains a drug.

According to a preferred embodiment of the present invention, step (a) inserts the contact projection of the lifting support into the opening of the substrate to which the viscous composition has not been applied, and then applies the viscous composition to the opening of the substrate to apply the viscous contact of the lifting support to the viscous composition. It is carried out by contacting the composition.

In the fabrication of the microstructure of the present invention, a substrate having a predetermined size of holes is used. According to [1] the solid substrate can be made of a material such as glass, PMMA, stainless steel, the number of holes is the same as the number of contact projections of the lifting support. The distance between the center and the center of the hole is also equal to the distance between the center and the center of the contact projection of the lifting support, and the substrate has a hole about 0.3 to 0.4 mm larger than the diameter of the contact protrusion for a smooth fabrication process and fabrication of a desired microstructure. It is useful to use. The shape of the substrate may be variously manufactured as shown in (a) or (b) of FIG. 1. In terms of drug loss, the thinner the substrate, the better.

Before preparing the viscous material on the substrate, the lifting support is raised to raise the contact protrusion to fit the hole of the substrate to fix the height. The contact protrusion is raised slightly higher than the height of the substrate (0.1 ~ 0.2mm) so that the upper end portion of the contact protrusion during the loading of the viscous material in step (b) sufficiently. At this time, the contact projection should be exactly coincident with the center of the substrate hole.

Subsequently, the polymer viscous material mixed with the drug is sprayed in a predetermined amount to match the size of the hole of the substrate and contacted with the contact protrusion. Viscosity and surface tension allow the substrate to be loaded in such an amount as to cover the holes of the substrate without spreading upon loading. Preferably, all holes of the substrate should be loaded with the same amount of viscous material, but even if there is a slight error, the size and shape of the finished microneedle were confirmed to be the same. Most preferably, the dispenser system can be used to load the same amount at the exact location of all holes in the substrate. Finally, the amount of viscous composition to be loaded is adjusted to match the volume of the microstructure to be manufactured.

One specific embodiment of the lifting support is illustrated in FIG. 2. The lifting support includes one or more contacting protrusions, and the inner diameter, number, and spacing of the contacting protrusions may be variously manufactured in some cases.

Step (b): descending of the ventilated contact projection

Subsequently, the viscous composition is blown into the viscous composition and the contact protrusion is lowered or the contact protrusion is lowered and then blown into the viscous composition to condense and solidify the viscous composition.

According to a preferred embodiment of the present invention, step (b) is carried out by lowering the contact protrusion in contact with the viscous composition at a low speed and then at a high speed. More preferably, step (b) is (b-1) first lowering the contact protrusion in contact with the viscous composition at a low speed to form a first descending result, (b-2) the first (B-3) forming the third falling result by lowering the second falling result at a high speed to form a second falling result and (b-3) lowering the second falling result at a lower speed. It includes.

According to a preferred embodiment of the present invention, step (b-1) is carried out simultaneously with the blowing or the blowing is carried out after the first descending is finished.

According to a preferred embodiment of the present invention, step (b-2) is carried out simultaneously with the blowing or the blowing is carried out after the second lowering is finished.

According to a preferred embodiment of the present invention, step (b-3) is carried out simultaneously with the blowing or the blowing is carried out after the third descending is finished.

According to a specific embodiment of the present invention, step (b) is composed of a total of three steps (or four steps).

(b-1) Primary lifting: blowing after contact with viscous objects of contact and lowering support under substrate hole

(b-2) blowing and tightly coupling the contact protrusion and the viscous substance

(b-3) Secondary lifting: blowing down the support rapidly

(b-4) 3rd lifting: blowing down the support slowly

The blowing method is carried out in four directions from east to west to north to produce a uniform microstructure.

(b-1) 1st lifting : blows after contacting contact point with viscous material and lowers the lifting support so that contacting contact is about 0.1 ~ 0.3mm below the board. At this time, the lifting speed of the lifting support is preferably about 0.2 ~ 0.4mm / min, and the contact protrusion does not fall below 300㎛ below the substrate. This step is to tightly bond the viscous composition and the contact projections so that the middle portion of the intermediate structure is cut in step (e). If the viscous composition does not bond tightly with the contact projection, the contact projection portion is cut instead of the center portion of the intermediate structure in step (e). The speed of the lifting support is adjusted to 0.2 ~ 0.4mm / min, because the viscous composition can come down through the hole after contact with the contact protrusion. The lower the viscosity of the viscous composition, the faster the first lifting speed, but preferably in the range of 0.2 ~ 0.4mm / min.

(b-2) Stop the support and blow for 5 minutes to bond the viscous composition below the substrate to the contact projection.

(b-3) Secondary lifting : Then, blow at a high speed of 5.0 ~ 7.0mm / min and lower for 5 ~ 10 seconds. The faster the descending speed of the lifting support is, the smaller the diameter of the fabricated microstructure is. Therefore, step (c-3) is to make the diameter of the middle part of the intermediate structure to be finally made as small as possible so that the middle part of the intermediate structure can be cut later when detached from the contact protrusion. The cut portion corresponds to the upper end of the finally produced microstructure.

(b-4) Third Lifting : Finally, lift the lifting support at the speed of 0.1 ~ 0.15mm. This step is to make the lower end of the microstructure to be manufactured to have a sufficient diameter. When descending at a speed of 0.1 ~ 0.15mm, the diameter of the microstructure produced is about 300㎛ so that it has sufficient strength.

In general, the faster the lifting speed, the smaller the inner diameter of the contact protrusion, the smaller the blowing strength, the lower the viscosity of the viscous material, the smaller the diameter of the finished microstructure. By adjusting the above four factors (lifting speed, inner diameter of contact protrusion, blowing strength, viscosity of viscous material), various shapes (diameter upper / lower part diameter, length from upper part to lower part, middle part between upper part and lower part Microstructures) can be produced.

Viscosity of the viscous composition, the moving speed of the lifting support, the diameter change of the upper end of the microstructure according to the blowing speed in the state of fixing the moving distance of the lifting support and the viscosity of the viscous composition, the lifting support in the state of fixing the moving distance and the blowing speed of the lifting support Looking at the diameter change of the upper end of the microstructure according to the moving speed of as described below. The following experimental results are the results obtained by maintaining the speed of the lifting support during manufacture of the microstructure without changing the intermediate. The analysis of the experimental results was focused on the "diameter of the upper end" because the diameter of the upper part is closely related to the strength, and the overall volume of the finally produced microstructure is also proportional to the diameter of the upper part. For this reason, the microstructure is manufactured by dividing into several steps while changing the lifting speed in step (c).

15 is a graph showing the change in diameter of the upper end of the microstructure according to the speed of the lifting support, the diameter change of the upper end of the microstructure according to the wind speed. The type and viscosity of the viscous substance, the inner diameter of the contact protrusion (300㎛), the final length (800㎛) of the fabricated microstructures, etc. were all kept the same experiment.

Once the upper diameter of the microstructure according to the speed of the lifting support is examined, the upper diameter becomes smaller as the speed increases, and it is confirmed that there is no significant change in the upper diameter when the speed becomes 0.6 mm / min or more.

In the change of the diameter of the upper end of the micro structure according to the wind speed, it was confirmed that the diameter of the upper end is relatively smaller than the speed of the slow wind when the wind speed is high, and the effect of the wind speed on the upper diameter decreases as the speed of the lifting support increases.

16 is a graph illustrating the change in diameter of the upper end of the microstructure according to the speed of the lifting support when manufacturing without blowing. The type and viscosity of the viscous substance, the inner diameter of the contact protrusion (300㎛), the final length (800㎛) of the fabricated microstructures, etc. were all kept the same experiment. The viscous composition was applied as thinly as possible on the substrate, and the total manufacturing time (time for evaporating the moisture of the viscous material) without blowing was about 3 hours. The faster the support, the smaller the top diameter. In the case of the speed of 0.05mm / min, more than 90 were possible in manufacturing 100 microstructure array types, and in the case of the speed of 0.1mm / min, it was manufactured in 20 or less. This is because the viscous composition that escapes through the substrate hole immediately solidifies and forms a microstructure without breaks when there is a blow. The structure is broken. When the lifting support is slow (0.05mm / min or less), the viscous composition solidifies slowly without blowing, but when the speed increases, the cohesive force to be sucked back through the hole in the substrate before the viscous composition solidifies (the viscosity on the substrate). Since the amount of the composition is relatively higher than the amount escaped below the substrate, the microstructure is broken by the property of being sucked back above the hole.

FIG. 17 is a photograph of a microstructure manufactured when the blowing method is applied (a) and when it is not applied (b). The round bottom is the structure made by the hole of the board and is the same size as the hole. In the case of (B) shown in FIG. 17, a thin film is formed around the rounded edge, which appears to be formed by solidifying with the viscous composition partially exiting to the outermost part of the substrate hole when the contact protrusion descends. In case of (a), the viscous composition can be manufactured without blowing out of the hole because of the ventilation.

18 is a view showing a schematic process when the speed of the lifting support without the blowing at a certain speed (0.1mm / min or more). The contact protrusion is brought into contact with the viscous composition through the hole of the substrate and lowered. After descending to the desired length, the overall diameter of the intermediate structure decreases over time, and at some point, the intermediate structure breaks, and the broken upper viscous composition is sucked through the hole in the substrate. In order to manufacture the intermediate structure without blowing air, the speed of the lifting support should be lowered to 0.05mm / min or less. Then, the diameter of the upper end of the finally produced microstructure is made larger than 100 μm to provide a structure having a desired shape. It can not be obtained and the production time also takes a disadvantage of more than three hours.

In the top-down manufacturing process, from the lower end of the microstructure having a length of 1 mm or less to about 30% in the direction of the upper end, it becomes as small as about 70% of the base diameter. Afterwards, the diameter shows a continuous linear decrease toward the upper end, and the upper end decreases within 20% of the diameter of the base (FIG. 21). The tapering of the upper end of the microstructure is a result of the tapering of the middle part of the intermediate structure as the lowering of the fast lifting support at a high speed in the secondary lifting step and the cross section corresponds to the upper end at the time of cutting.

From the lower end of the microstructure having a length of 1 to 2 mm to about 30% from the upper end direction, it was about 80% of the base diameter and showed the same tendency as the above 1mm length. Afterwards, the diameter continues to decrease toward the top end and within 20% of the base diameter at the top end (FIG. 21). The thinning of the upper end of the microstructure is a result of the tapering of the middle part of the intermediate structure as the lowering of the fast lifting support at a high speed in the secondary lifting step, and the lower part of the microstructure is lowering the lifting support slowly in the third lifting step. This is because the length of the lower end portion is increased in diameter as the length of time is increased compared to the case having a length of 1mm or less above.

From the lower end of the microstructure having a length of 2 mm or more to about 30% in the direction of the upper end, it becomes as small as about 90% of the base diameter. Afterwards, the diameter continues to decrease toward the top end and within 20% of the base diameter at the top end (FIG. 21). The thinning of the upper end of the microstructure is a result of the tapering of the middle part of the intermediate structure as the lowering of the fast lifting support at a high speed in the secondary lifting step, and the lower part of the microstructure is lowering the lifting support slowly in the third lifting step. This is because the length of the lower end portion is made thicker as the length of time is increased compared to the case having a length of 1 ~ 2mm above.

Step (bc): Application of the Viscous Composition on the Substrate

According to a preferred embodiment of the invention, the method further comprises the step (bc) of applying a viscous composition on the substrate between steps (b) and (c).

According to a preferred embodiment of the invention, the viscous composition does not comprise a drug.

According to a preferred embodiment of the present invention, the viscous composition applied on the substrate is solidified by blowing.

Each of the microstructures fabricated in step (b) is fabricated by separating the structures from each other by injecting a viscous composition into each hole in step (a) when viewed from above the substrate. As a result, the contact area between the microstructure and the solid substrate is small so that the center portion of the intermediate structure is not cut during cutting, and the entire intermediate structure is pulled out through the hole of the substrate while being coupled to the contact protrusion away from the solid substrate. To prevent this, the viscous substance consisting of pure polymer without drug is applied and solidified by applying a small amount thinly and blowing (10min ~ 15min) to cover all the holes of the solid substrate. In this case, as the separated structures are strongly connected to each other and solidified, the middle portion of the intermediate structure may be cut off when cutting in step (c).

Step (c): separating the contact protrusion from the microstructure

In the result of step (b), the lowering of the lifting support at a high speed cuts off the center portion of the finished microstructure. This is related to the process of raising the contact protrusion in the step of (a) about 0.1 ~ 0.2mm above the hole of the substrate to sufficiently couple to the upper end of the contact protrusion when loading the viscous composition in step (a). The viscous composition and the contact protrusion must be firmly coupled so that the center part of the microstructure is cut in step (c) and can be cut at the end of the contact protrusion if it is not firmly coupled. In this case, a thin film having the same diameter as the contact protrusion is formed at the upper end of the microstructure to be finally manufactured, and there is a problem that a separate cutting process is required to remove it. If the contact projections are made more hydrophilic through plasma treatment, they can be more strongly combined with the viscous composition.

Another method of cutting is to create a beveled angle so that the top of the microstructure is made sharper with a UV laser system.

Step (d): Attach the adhesive patch to separate the completed microstructures from the substrate

According to a preferred embodiment of the present invention, after step (c), step (d) further comprises the step of attaching the adhesive patch on the substrate and then separating the solid microstructure with the adhesive patch attached from the substrate.

The completed array type microneedles are easily separated from the solid substrate, so that the adhesive patch is slightly larger than the size of the solid substrate and is separated from the substrate. The substrate can be reused immediately after cleaning, and the finished microneedles are attached to flexible adhesive patches rather than rigid solid substrates, which can be usefully applied to curved skin surfaces.

According to a preferred embodiment of the present invention, the microstructures of the present invention have a top diameter of 1-500 μm, more preferably 2-300 μm, most preferably 5-100 μm, Preferably it has an effective length of 100-10,000 μm, more preferably 150-10,000 μm, even more preferably 200-8,000 μm, most preferably 250-2,000 μm.

Looking at the structure of the microneedle, the diameter ratio of the upper end and the lower end of the microneedles varies depending on the type and concentration of the viscous composition, and has a diameter ratio of at least 1: 1.5 to 1: 1000. The microneedles preferably have a diameter ratio of at least 1: 3 or more, more preferably 1: 5 or more in order to have strength for skin penetration. It was also confirmed that the top-down lifting method has a larger diameter ratio at the top and bottom than the bottom-up lifting method.

Blowing is made in the direction in which the viscous composition is located and the production is made, but is made in a symmetrical direction, such as two directions, four directions, but is not limited thereto. Blowing may also take place through the tuyeres in the lifting support.

The experiment was performed by adjusting the diameter of the contact protrusion of the lifting support to 50 ~ 1000 ㎛. As the diameter of the contact protrusion increases, the diameter of the manufactured microneedles increases, and as the diameter of the contact protrusion decreases, the diameter of the manufactured microneedles decreases. However, when the contact protrusion diameter was less than 100 ㎛ did not show a big difference between each other. In order to have an effective diameter (80 μm or less) for the microneedle, it is preferable to manufacture the contact needle having a diameter of 500 μm or less because it is difficult to manufacture when the diameter of the contact protrusion exceeds 500 μm.

The microstructure that can be loaded with multi-drugs has two or more biodegradable drugs mounted on the drug and has two or more drug release control capacities. In the fabrication of microstructures containing microparticles, the viscosity of the biodegradable substance containing microparticles is smaller than that of the biodegradable substance containing no microparticles, and stronger blowing is required for rapid fabrication.

According to one aspect of the present invention, the present invention provides a method for producing a multi-drug solid microstructure comprising the following steps:

(a) preparing a biocompatible / biodegradable material as a backbone of the microstructures;

(b) mixing the biocompatible / biodegradable material and drug of (a), wherein the drug is incorporated into microparticle, nanoparticle and emulsion formulations; And,

(c) preparing a solid microstructure containing the drug carrier using the mixture of (b).

According to the present invention, it is possible to adjust the release rate of the drug, which could not be manufactured by the prior art, or to release the mixed form or multiple drug release as a multi-drug by adding a mixed form of water-soluble and fat-soluble drugs, a cosmetic ingredient, or a polymer substance. It has been found that solid microstructures can be made while still having desired properties (eg, effective length, top diameter and hardness).

The method of the present invention will be described in detail with each step as follows:

Step (a): Preparation of biocompatible / biodegradable material as backbone material of the microstructures

The material used in the present invention for preparing the microstructures is a biocompatible / biodegradable material. As used herein, the term biocompatible material means a material that is substantially nontoxic to the human body, chemically inert and immunogenic. As used herein, the term biodegradable material means a material that can be degraded by body fluids or microorganisms in a living body.

The biocompatible / biodegradable material that forms the backbone of the microstructures may itself be viscous or include other viscosity modifying agents. The viscosity of such biocompatible / biodegradable materials can be varied in various ways depending on the type, concentration, temperature or addition of thickener, etc., and can be adjusted to suit the purposes of the present invention.

For example, thickeners commonly used in the art such as hyaluronic acid and salts thereof, polyvinylpyrrolidone, cellulose polymers, dextran, gelatin, glycerin, polyethyleneglycol, polysorbate, propylene glycol, Povidone, carbomer, gum ghatti, guar gum, glucomannan, glucosamine, dammer resin, rennet casein, locust bean gum, microfibrillated cellulose ), Psyllium seed gum, xanthan gum, arabino galactan, arabian gum, alginic acid, gelatin, gellan gum, carrageenan, karaya gum, curdlan ( curdlan, chitosan, chitin, tara gum, tamarind gum, tragacanth gum, furcelleran, pectin or pullulan Thickener of solid microstructure Viscosity can be adjusted to suit the present invention by addition to a main component such as a biocompatible / biodegradable material.

According to a preferred embodiment of the present invention, the biocompatible / biodegradable material used in the present invention is dissolved in a suitable solvent to exhibit viscosity.

The solvent used to prepare the biocompatible / biodegradable material is not particularly limited and includes water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, dichloromethane, 1,3-butylene Glycol, hexane, diethyl ether or butyl acetate can be used as the solvent.

Step (b): mixing biocompatible / biodegradable materials and drugs

Next, as a step of mixing the biocompatible / biodegradable material and the drug, the drug is allowed to be incorporated into the microparticle, nanoparticle and emulsion formulations.

As used herein, the term microparticles refers to microsized microspheres in which the drug is encapsulated, and nanoparticles refers to nanosized microspheres in which the drug is encapsulated. As used herein, the term emulsion formulation is in the form of an emulsified drug in a biocompatible / biodegradable substance that is a framework of a solid microstructure.

Biocompatible / biodegradable materials as skeletal materials of the solid microstructures and drugs incorporated into the formulations can be mixed in a variety of ways.

A preferred embodiment of a solid structure capable of representative multiple drug release is described as follows:

The solid microstructure includes both microparticles or nanoparticles and emulsions (including water-in-oil, oil-in-water or multiple emulsions) as drug carriers (see FIG. 11). In the case of the emulsion formulation, the method of emulsifying the drug in a biocompatible / biodegradable substance that is a skeleton of the solid microstructure may be prepared using various methods known in the art. More specifically, it can be produced in oil-in-water (O / W) emulsion type, multiple emulsion type and the like. The method of preparing the emulsion may preferably disperse the drug directly in a biocompatible / biodegradable material without an emulsifier to produce an emulsion containing the drug, or may include the drug using a variety of natural or synthetic emulsifiers. In the case of using an emulsifier, more preferably, it may be stabilized using a lecithin, borax, stearic acid, amisol soft, helio gel, beeswax, xanthan gum, emulsion wax or solubilizer as a natural emulsifier. PEG-8 dilaurate, PEG-150 distearate, PEG-8 stearate, PEG-40 distearate, PEG-100 disoem as an emulsifier for oil-in-water emulsions Consists of sorbitan stearate, sorbitan oleate, sorbitan sesquioleate, and sorbitan trioleate, emulsifiers for tearate and water-in-oil emulsions Selecting from the group or combining them to produce an emulsion containing a drug, most preferably an emulsion without an emulsifier. For example, the mixture can be prepared by emulsifying a fat-soluble drug in a water-in-oil (W / O) type with a homogenizer in a water-soluble biocompatible / biodegradable material. The size of the emulsion of the drug to be produced depends on the homogeneity rate of the emulsion.

The method of mixing the particles with a biocompatible / biodegradable material can be made using a variety of methods known in the art. For example, microparticles or nanoparticles can be mixed with biocompatible / biodegradable materials by multiple emulsion methods, dispersion dry methods or particle precipitation methods.

Microparticles or nanoparticles comprising the drug are preferably polyesters, polyhydroxyalkanoates (PHAs), poly (α-hydroxyacid), poly (β-hydroxyacid), poly ( 3-hydrobutyrate-co-valorate; PHBV), poly (3-hydroxyproprionate; PHP), poly (3-hydroxyhexanoate; PHH), poly (4-hydroxyacid) , Poly (4-hydroxybutyrate), poly (4-hydroxy valerate), poly (4-hydroxyhexanoate), poly (esteramide), polycaprolactone, polylactide (PLA), polyglyco Ride (PGA), poly (lactide-co-glycolide; PLGA), polydioxanone, polyorthoesters, polyanhydrides, poly (glycolic acid-co-trimethylene carbonate), polyphosphoesters, poly Phosphoester Urethane, Poly (Amino Acid), Polycyanoacrylic , Poly (trimethylene carbonate), poly (iminocarbonate), poly (tyrosine carbonate), polycarbonate, poly (tyrosine arylate), polyalkylene oxalate, polyphosphazene, PHA-PEG, polyvinylpyrroli Don, polybutadiene, polyhydroxybutyric acid, polymethyl methacrylate, polymethacrylic acid ester, polypropylene, polystyrene, polyvinyl acetal diethylamino acetate, polyvinyl acetate, polyvinyl alcohol, polyvinylbutyral, polyvinyl Foam, vinyl chloride-propylene-vinylacetate copolymer, vinyl chloride-vinylacetate copolymer, coumaronenate polymer, dibutylaminohydroxypropyl ether, ethylene-vinylacetate copolymer, glycerol distearate, 2-methyl- 5-vinylpyridine methacrylate-methacrylic acid copolymer, hyaluronic acid, myristic acid, palmitic acid, ste Leric acid, behenic acid, cellulose or derivatives thereof, maltose, dextran, glucomannan, glucosamine, chitosan, heparin, alginate, inulin, starch, glycogen, chitin, chondroitin, dextrin, keratan sulfate, tallow, whale wax, beeswax, paraffin Waxes or castor waxes, more preferably polylactide (PLA), polyglycolide (PGA), poly (lactide-co-glycolide); PLGA), cellulose or derivatives thereof, maltose, dextran, glucomannan, glucosamine, chitosan, heparin, alginate, inulin, starch or glycogen, most preferably polylactide (PLA), polyglycolide (PGA), poly (Lactide-co-glycolide; PLGA), cellulose or a derivative thereof, maltose or chitosan. When using a cellulose derivative as a biocompatible / biodegradable material, it is preferably a cellulose polymer, even more preferably hydroxypropyl methylcellulose, hydroxyalkyl cellulose (preferably hydroxyethyl cellulose or hydroxypropyl cellulose), Ethyl hydroxyethyl cellulose, alkyl cellulose and carboxymethyl cellulose, even more preferably hydroxypropyl methyl cellulose or carboxymethyl cellulose, most preferably carboxymethyl cellulose.

According to a preferred embodiment of the present invention, the biocompatible / biodegradable material as the framework material of the microstructures used in the present invention is a material different from the microparticles or nanoparticles.

According to a preferred embodiment of the present invention, the biocompatible / biodegradable substance as a skeletal substance of the microstructures used in the present invention further comprises a drug. The drug included is not limited, but more preferably the drug included in the biocompatible / biodegradable material is different from the microparticles or nanoparticles, or the drug included in the emulsion, and most preferably the backbone of the microstructure, microparticles Or nanoparticles, and emulsions each contain a different kind of drug.

One of the biggest features of the present invention is to prepare a microstructure capable of controlling multiple drug release by mounting a variety of drugs in the microstructure. As used herein, the term drug release control is a biocompatible / biodegradable material and microparticles or nanoparticles using different properties of the time and degree of biodegradation in the body, respectively, different drugs have different drug delivery efficacy in vivo as needed It can be adjusted.

Another feature of the present invention is to mount one drug in a microstructure in various ways. In this case, by using the property that the skeleton, microparticles or nanoparticles of the microstructures are decomposed at different rates, a microstructure that is controlled to enable drug release at a desired time even with the same drug may be manufactured.

Drugs used in the present invention are not particularly limited, preferably the drug contained in the microparticles or nanoparticles and the drug contained in the emulsion is released at different rates, most preferably the skeleton of the microstructure The drug contained in the substance and the drug contained in the microparticles, nanoparticles or emulsions are released at different rates [FIG. 12].

As used herein, the term “top end” of a microstructure refers to one end of the microstructure having the smallest diameter. As used herein, the term “effective length” means the vertical length from the top of the microstructure to the support surface. As used herein, the term “solid microneedles” refers to microneedles made integrally without forming hollows.

The present inventors have sought to develop a solid microstructure which has a micro-unit diameter, sufficient effective length and hardness, and can easily contain heat-sensitive drugs without modification or inactivation. As a result, it was possible to manufacture a solid microstructure by blowing without heat treatment, and the manufacturing process was able to manufacture from the bottom up or top down.

By solidifying the viscous material by blowing air without any heat treatment, it was possible to develop a solid microstructure that can easily contain heat-sensitive drugs without denaturation or inactivation.

Blowing used in this method maximizes its effectiveness when used on water-soluble materials. This is because when the water-soluble substance is dissolved in water, it is manufactured on the principle that solidification occurs between water-soluble substances by evaporating moisture by blowing air. First, in order to solidify the water-soluble material, it is necessary to form an intermediate structure through the lifting support, and as the water evaporates, the water-soluble material is solidified to the intermediate structure to produce a microstructure. Zero airflow cannot efficiently induce coagulation of the water-soluble substance, and thus cannot produce a microstructure having a diameter in micro units, an effective effective length, and a hardness. This method is not limited to water-soluble substances but is not greatly affected by blowing in the case of heat solidified substances (PLA, PLG, SU-8, maltose, etc.). However, in the case of the material which is solidified by heat, the heat-sensitive drugs such as biopharmaceuticals cannot be mounted on the microstructure without denaturation or inactivation because the high temperature process is performed during the manufacture of the microstructure.

Blowing was able to efficiently induce coagulation of the viscous material to produce a solid microstructure, the solid microstructure was prepared while lifting the viscous material from the bottom up.

In the case of the bottom-up lifting method, a drug-loaded viscous composition was coated on the substrate or a dispenser device was used to spray the same amount at the correct position, thereby significantly reducing the drug loss rate. In addition, the production time may be performed discontinuously in steps [a-d] of FIG. 3 and [e-f] of FIG. 3, and thus, a substrate having a viscous composition base structure is performed in advance. Can be produced in a large amount, so that the manufacturing process of the microstructure mounted with the drug has a fast manufacturing time of about 7 to 10 minutes. This is a 10-15 minute time savings compared to the top-down lifting method.

In the case of the top-down lifting method, unlike the bottom-up method, it was possible to produce a solid microstructure having a uniform shape without interference between the structures, and having a micro-unit diameter, sufficient effective length and hardness, and counter to gravity Compared with the bottom-up method, the top-down lifting method was used to produce the microstructure without limiting the length. In addition, in the step of preparing a viscous substance on the substrate, a certain amount of viscous substances are sprayed into the holes of the substrate to minimize the loss of drugs. In addition, it was confirmed that the diameter ratio of the upper end and the lower end of the microstructure is relatively larger than the bottom-up lifting method when fabricating the contact protrusion of the same diameter, which is more useful when manufacturing a microstructure having a length of 300 μm or less for the cosmetic microneedle patch. It was confirmed that it can be applied.

It was possible to manufacture solid microstructures capable of multi-drug release by bottom-up and top-down methods, using viscous materials in water-in-oil (O / W) emulsions containing fat-soluble drugs and microparticles loaded with drugs. It is possible to produce a solid microstructure capable of multiple drug release. 11

The features and advantages of the present invention are summarized as follows:

(Iii) The present invention is a method for producing a solid microstructure through a process including a contacting step, a blowing step, a condensation step and a solidification step without heat treatment, and this strategy has not been conventionally adopted.

(Ii) According to the present invention, since the drug-containing viscous composition is spotted on the base structure by the required amount, the microstructure is manufactured, and thus, the drug can be loaded in the microstructure without the loss of the drug to be loaded. And suitable for delivering functional materials.

(Iii) According to the present invention, a microstructure is prepared by loading a drug-containing viscous composition onto a substrate within 10 minutes, which is 10 times faster than the conventional method.

(Iii) According to the present invention, by using a top-down lifting method corresponding to gravity, the microstructure can be manufactured without limitation in length in proportion to the amount of the viscous material applied to the substrate, and the microstructure does not bend or fall off from the contact protrusion during the production. There is an advantage.

(Iii) According to the present invention, when a viscous material is loaded onto a substrate, each jet is injected into the hole of the substrate, and thus, when the structure is prepared by loading different drugs, a microstructure in which multiple drugs are mounted on one substrate can be manufactured.

(Iii) According to the present invention, since the viscous material is sprayed into the holes of the substrate when loading on the substrate, it is possible to minimize the loss of drugs.

(Iii) According to the present invention, since a solid substrate having a hole can be manufactured without interference between structures, narrowing the gap of the holes (as well as the gap of the contact protrusions) can increase the number of micro structures per unit area and consequently, It is possible to fabricate a solid microstructure in which a large amount of drug is mounted on a single solid substrate manufactured by the method.

(Iii) According to the present invention, the finally completed microneedle array is attached on the adhesive patch and at the same time as the production is completed, it can be attached to the skin to see the drug effect. Substrates used in manufacturing can be reused immediately after cleaning, thus reducing the cost of manufacturing the substrate. In addition, the completed microneedle array is combined with a flexible adhesive patch, which can be usefully applied to curved skin.

(Iii) According to the present invention, it was confirmed that the diameter of the lower end is smaller than the bottom-up lifting method when manufacturing the microstructure with the contact diameter of the same diameter, which is more than when manufacturing the microstructure of 300㎛ or less for the purpose of cosmetic patch It can be usefully applied.

(Iii) According to the present invention, it is possible to produce a solid microstructure having a diameter, sufficient effective length and hardness of micro units, and which can easily contain heat-sensitive drugs without denaturation or inactivation.

(xi) According to the present invention, it is possible to produce a solid microstructure having the desired properties (eg, effective length, top diameter and hardness) at a simple, quick and low cost of production.

(xii) According to the present invention, it is possible to prepare a solid microstructure having multidrug loading and multidrug release control ability.

1 shows one specific embodiment of a bottom-up lifting support having a tuyeres used to make the microstructures of the present invention.
2 is an embodiment schematically showing a process of manufacturing the microstructure of the present invention using the tuyeres.
Figure 3 is an embodiment schematically showing a process of manufacturing the microstructure of the present invention without the tuyere.
4 shows a patterned microstructure formed on a substrate according to the method of the present invention. Panel a is a plan view of the microstructure, panel b is a front view of the microstructure, and panel c is a perspective view of the microstructure.
5 shows one specific embodiment of a solid substrate used to fabricate the microstructures of the present invention. (a), (b) is a top view, (c), (d) is a front view of (a), (e) is a front view of (b).
6 shows one specific embodiment of the lifting support used to make the microstructures of the present invention.
7 is an embodiment schematically showing a process of manufacturing a microstructure of the present invention.
8 shows a patterned microstructure formed on a substrate according to the method of the present invention. Panel a is a front view of the microstructure, panel b is a top view of the microstructure, and panel c is a perspective view of the microstructure.
Figure 9 is an embodiment schematically showing a process for manufacturing a microstructure mounted with different drugs of the present invention.
FIG. 10 is an embodiment schematically illustrating a process of manufacturing a microstructure having a shorter effective length (within 350 μm) of the present invention.
11 is a microparticle or nanoparticle comprising a fat-soluble drug in an oil-in-water emulsion (O / W) method and a biocompatible / biodegradable material including a water-soluble drug according to an embodiment of the present invention. Figure showing the structure of a solid microneedle capable of controlling multiple drug release by mixing.
FIG. 12 is a diagram illustrating a patch type of the solid structure capable of releasing the multi-drug of FIG. 11, which is an embodiment of the present invention, and applied to the skin. FIG. Panels a to c show multiple drug release control processes, with panel a showing the biocompatibility / biodegradable material begins to decompose when microneedle is applied to the skin, and panel b shows simultaneous delivery of water-soluble and fat-soluble drugs. Panel c shows the final release of the drug contained in the microparticles or nanoparticles.
FIG. 13 is a diagram illustrating a case where a microstructure is manufactured without a blowing process.
14 is a graph showing the change in diameter of the microstructure according to the lifting speed, the diameter change of the microstructure according to the wind speed.
15 is a graph showing the change in diameter of the upper end of the microstructure according to the speed of the lifting support, the diameter change of the upper end of the microstructure according to the wind speed.
16 is a graph illustrating the change in diameter of the upper end of the microstructure according to the speed of the lifting support when manufacturing without blowing.
FIG. 17 is a photograph of a microstructure manufactured when the blowing method is applied (a) and when it is not applied (b).
18 is a view showing a schematic process when the speed of the lifting support without the blowing at a certain speed (0.1mm / min or more).
FIG. 19 is a view showing the shape of a microstructure that varies with controlling the speed of the blowing and lifting support.
20 is a photograph showing the morphological features of the microstructures produced by the bottom-up method.
21 is a photograph showing the morphological features of the microstructure produced by the top-down method.

Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for describing the present invention in more detail and that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention .

Example

Example I

Carboxymethylcellulose high viscosity (Sigma) was used as a viscous composition (21) to prepare a microstructure. 0.4 mg of carboxymethylcellulose was dissolved in 20 ml of tertiary distilled water to give a solution of 2% (w / v). After coating 2% carboxymethylcellulose on the glass substrate 20, the lifting support 10 which has the contact protrusion of 3x3 of 500 micrometers in diameter was contacted (a of FIG. 2). 5 minutes after the contact of the lifting support was passed through the air vent 12 to make a strong contact with the contact projections while weakly curing the carboxymethyl cellulose (b of Figure 2). The lifting support was lifted at a rate of 11.945 μm / s for 1 minute (total lifting height: 716.7 μm) to form an intermediate structure 23 (c in FIG. 2). The moisture of the carboxymethylcellulose was dried while continuing to pass the wind 22 through the tuyeres between the substrates after the lifting support contact (FIG. 2 d). As the moisture dried, the carboxymethylcellulose from the lifting support to the substrate was hardened to form a microneedle (FIG. 2 e). Solid microneedle completed curing was cut out using fine scissors (Fig. 2 f). As a result, a microneedle 30 having an upper diameter of 50 µm and an effective length of 1,200 µm was manufactured (FIG. 3). At this time, the diameter of the microneedle can be adjusted by changing the diameter of the contact protrusion. In addition, it was confirmed that the shape of the solid microneedles formed by changing the strength of the wind passing through the tuyeres or the viscosity of the carboxymethyl cellulose. Carboxymethylcellulose low viscosity (Sigma) when using a low viscosity of 10% (w / v) to be produced in the form of a microneedle was possible to manufacture a needle having a larger diameter.

In addition, a microstructure was prepared using chitosan low molecular weight (Sigma) as a viscous composition (21). 100 μl of acetic acid was mixed in 10 ml of tertiary distilled water, and 0.46 g of chitosan was dissolved to prepare a 30% (w / v) chitosan viscous substance. After applying 100 μl of the prepared chitosan viscous material on the prepared substrate 20, the lifting support 10 having a 4 × 4 contact protrusion having a diameter of 400 μm was contacted with chitosan. The chitosan was hardened by blowing for 5 minutes, and the contact protrusion and the chitosan were solidified so as to be in strong contact. The lifting support was lifted for 30 seconds at a speed of 0.6 mm / min and the speed was lowered for 2 minutes and 30 seconds at a speed of 0.2 mm / min while maintaining a weak blowing to form an intermediate structure 23 (bd of FIG. 2). . After the lifting process was blown vigorously for about 15-20 minutes to cure the viscous material was produced in the form of a microneedle (Fig. 2e). The hardened microstructure was cut out using fine scissors (FIG. 2 f). As a result, the finished microstructure was confirmed to be manufactured with an upper diameter of 50 μm and an effective length of 800 μm (FIG. 3). At this time, by changing the diameter, lifting speed, and time of the contact protrusion, the diameter and length of the microneedle can be adjusted.

As another viscous composition (21), microstructures were prepared using hyaluronic acid sodium salt (Sigma). Dissolves 0.2 g of hyaluronic acid (100,000 to 1.50,000 MW) and 0.3 g of hyaluronic acid (1 million to 1.5 million MW) in 10 ml of distilled water, 33% (w / v) hyaluronic acid Made a Lonic acid viscous. After 100 μl of the prepared hyaluronic acid viscous material was applied onto the prepared substrate 20, the lifting support 10 having a 4 × 4 contact protrusion having a diameter of 400 μm was contacted with the viscous material. The hyaluronic acid was slightly cured by blowing for 5 minutes, and the contact protrusion and the hyaluronic acid were solidified so as to be in strong contact. The lifting support was lifted for 30 seconds at a speed of 0.6 mm / min and the speed was lowered for 2 minutes and 30 seconds at a speed of 0.2 mm / min while maintaining a weak blowing to form an intermediate structure (23) of FIG. 2. d). After the lifting process was blown strongly for about 15 to 20 minutes to cure the viscous material was produced in the form of a microneedle (Fig. 2e). The hardened microstructure was cut out using fine scissors (FIG. 2 f). As a result, the finished microstructure was confirmed to be manufactured with an upper diameter of 40 μm and an effective length of 800 μm (FIG. 4). At this time, by changing the diameter, lifting speed, and time of the contact protrusion, the diameter and length of the microneedle can be adjusted.

Microstructures were prepared using a viscous composition (21) in which hyaluronic acid sodium salt (Sigma) and Carboxymethylcellulose low viscosity (Sigma) were mixed. A viscous composition was prepared by dissolving 0.2 g of carboxymethyl cellulose and 0.2 g of hyaluronic acid (1 million to 1.5 million MW) in 20 ml of tertiary distilled water. After coating the mixed viscous composition on the substrate 20, the lifting support 10 having a 4 x 4 contact protrusion having a diameter of 500 µm was contacted (a of FIG. 2). 5 minutes after the contact of the lifting support was passed through the air vent 12 to make the mixed viscous composition weakly hardened to contact with the contact projections (Fig. 2b). The lifting support was lifted for 1 minute at a speed of 0.6 mm / min and lowered for 3 minutes at a speed of 0.1 mm / min (total lifting height: 900 μm) to form an intermediate structure 23 (see FIG. 2). c). After the lifting support contact, the moisture of the viscous composition was dried while continuously passing the wind 22 through the tuyeres between the substrates (d in FIG. 2). As the moisture dries, the carboxymethylcellulose and hyaluronic acid were cured from the lifting support to the substrate, and were manufactured in the form of microneedles (FIG. 2E). Solid microneedle completed curing was cut out using fine scissors (Fig. 2 f). As a result, a microneedle 30 having an upper diameter of 50 µm and an effective length of 1,200 µm was manufactured (FIG. 4). At this time, by changing the diameter, lifting speed, and time of the contact protrusion, the diameter and length of the microneedle can be adjusted.

In order to observe the change of the diameter of the microstructure according to the diameter of the contact protrusion, the microstructures were manufactured while adjusting the diameters to 200 μm, 250 μm, 300 μm, 350 μm, 400 μm, 450 μm and 500 μm. Carboxymethylcellulose low viscosity (Sigma) was used as a viscous composition, and 0.3 g of carboxymethylcellulose was dissolved in 30 ml of tertiary distilled water. After coating the viscous composition on the substrate 20, the lifting support 10 having the above-mentioned contact protrusions having a diameter of 200 µm to 500 µm was contacted (a in FIG. 2). 5 minutes after the contact of the lifting support was passed through the air vent 12 to make a strong contact with the contact projections while weakly curing the carboxymethyl cellulose (b of Figure 2). The lifting support was lifted for 1 minute at a speed of 0.6 mm / min and lowered for 3 minutes at a speed of 0.1 mm / min (total lifting height: 900 μm) to form an intermediate structure 23 (see FIG. 2). c). The moisture of the carboxymethylcellulose was dried while continuing to pass the wind 22 through the tuyeres between the substrates after the lifting support contact (FIG. 2 d). As the moisture dried, the carboxymethylcellulose from the lifting support to the substrate was hardened to form a microneedle (FIG. 2 e). When the diameter of the contact protrusion was 300 μm or more, the diameter of the microstructure also increased as the size of the contact protrusion increased.

Example II

Carboxymethylcellulose (Low viscosity, Sigma) was used as a viscous composition (21) to prepare a microstructure. 3 mg of carboxymethylcellulose was dissolved in 30 ml of tertiary distilled water to give a 10% (w / v) viscous solution. After applying 10% carboxymethyl cellulose to the substrate 20, the viscous composition was subsequently coated on the substrate by blowing (Fig. 3 ab). Thereafter, after spotting the viscous composition at a desired position (c in FIG. 3), a structure made of a viscous composition is made through blowing (d in FIG. 3). After spotting the drug-containing viscous composition on the structure (Fig. 3e), the lifting support 10 having a contact protrusion of 3 x 3 having a diameter of 500㎛ was lowered and contacted (Fig. 3f). After contacting the lifting support, the lifting support was first lifted at a speed of 10 μm / s for 5 to 15 seconds, followed by blowing for 5 seconds to 5 to 50 μm / s for 10 to 60 seconds. Car lifting (total lifting height: 766.7 μm) was formed to form the intermediate structure 30 (g in FIG. 3). It can be seen that the shape of the microneedle structure changes with the speed and time of lifting. Lifting speed is faster than 50 ㎛ / s, lifting for 10 seconds or more, the intermediate structure is not formed and the bond between the carboxymethyl cellulose and the contact protrusion is broken, so the lifting speed is dependent on the kind and concentration (viscosity) of the material Changes should be made accordingly. Blowing was carried out after the secondary lifting to dry the moisture of the carboxymethylcellulose (Fig. 3g). As the moisture dried, the carboxymethyl cellulose was hardened from the lifting support to the substrate to form a microneedle (h of FIG. 2). The hardened solid microneedle is cut off by lifting the support at high speed. As a result, a microneedle 31 having an upper diameter of 10 to 80 µm and an effective length of 500 to 3,000 µm was manufactured (h in FIG. 3). At this time, the diameter of the microneedle can be adjusted by changing the diameter of the contact protrusion. In addition, it was confirmed that changing the concentration (viscosity) of the carboxymethyl cellulose changes the shape of the solid microneedle formed. That is, as the concentration (viscosity) of the carboxymethyl cellulose was higher, the amount of the carboxymethyl cellulose contained in the same amount of the viscous solution was increased, so that the diameter of the microneedles was increased as a whole.

Notice :

When the intermediate structure is formed by lifting after contact, the secondary lifting speed is 5-50 μm / s. At this time, it is possible to adjust the overall length of the microneedle according to the lifting time. In this case, when the lifting speed for forming the intermediate structure is 5 μm / s or less, the diameter of the microneedles is large, and thus it is not effective for skin penetration. In addition, when the lifting speed exceeds 50 ㎛ / s it was confirmed that the intermediate structure is not formed and the bond between the contact projection and the viscous composition is broken. Of course, the rate is expected to vary depending on the viscosity of the viscous composition, but the carboxymethyl cellulose, chitosan, hyaluronic acid carried out to date shows this phenomenon.

Example III

Carboxymethyl cellulose (Low Molecular weight, Sigma) was used as a viscous composition to prepare the microstructure. 2.7 g of CMC (Carboxymethyl cellulose) was dissolved in 30 ml of tertiary distilled water to make 9% (w / v) viscous composition solution. A lifting support having a diameter of 500 μm, an interval of 1.6 mm between the centers of neighboring contact protrusions, and a number of contact protrusions 10 × 10 (100 units / 1.5 cm 2) was used. The hole was fixed to a diameter of 900 μm, a distance of 1.6 mm between the centers of adjacent holes, and a center of a solid steel hole having a thickness of 0.1 mm. At this time, the contact protrusion was raised 0.2mm above the hole of the substrate (Fig. 7-a). Then, the drug-loaded CMC solution was selected by a predetermined amount into each hole of the substrate (Fig. 7-b).

The lifting support was lifted at a rate of 0.4 mm / min for 1 minute and then strongly blown for 5 minutes to solidify the viscous composition below the substrate in a state of being attached to the contact protrusion, thereby strongly binding to the contact protrusion. Then, with strong blowing, descending quickly at a speed of 7.0 mm / min for 10 seconds, and lifting was stopped and then strongly blown for 2 minutes. Finally, blow down strongly for 4 minutes at a speed of 0.15mm / min. (Fig. 7-c, d)

As the moisture dries, the chitosan was cured from the lifting support to the substrate to form a microneedle. Once cured, the solid microneedles were applied with a small amount of pure CMC viscous material unloaded to cover all holes on the substrate before cutting (Fig. 7-e). This is to fix it firmly on the substrate. After solidifying all the CMC viscous materials with a strong blow, the lifting support is momentarily pushed down to cut off the center of the microstructure with a small diameter (Fig. 7-f). 800 micrometers microneedle was produced.

By changing the diameter of the contact protrusion, the viscosity of the viscous material, the blowing intensity, and the lifting speed, the upper end diameter, lower end diameter, effective length, and overall shape of the microstructure can be freely adjusted. In general, it was confirmed that the smaller the weave of the contact protrusion, the smaller the viscosity of the viscous material, the weaker the blower strength, and the faster the lifting speed, the smaller the diameter of the fabricated microstructure.

In the final step, a tacky patch was attached to the completed microneedle base and separated from the substrate (Fig. 7-g, h).

Example IV

Example IV is the same as in Example III and the solid microstructure fabrication process in all steps, the difference is that in step (b) to load the carboxymethyl cellulose viscosity loaded with different drugs. Chitosan viscosities mixed with Methylene blue and Texas red can be freely sprayed into each hole as many times as desired. The manufacturing process is the same as in Example III. Example IV is further specified through [Fig. 9].

Example Ⅴ

Example V is almost the same as the preparation method of Example II, except that chitosan low molecular weight (Sigma) was used instead of carboxymethyl cellulose as the viscous composition used to fabricate the microstructure. 0.92 g of chitosan was dissolved in 20 ml of tertiary distilled water (1% CH ₃ COOH) to form a viscous composition solution. The difference from Example I is that the loading of the viscous composition is finished in step (b), followed by strong blowing for 3 minutes before the lifting process in step (c). This is because the viscosity of chitosan is relatively small compared to carboxymethyl cellulose, so it was necessary to make it after blowing for 3 minutes and evaporating the water to some extent to make the viscosity higher. The rest of the steps were the same as in Example II, and finally, a microneedle having an upper end diameter of 50 μm and an effective length of 800 μm was produced.

Example VI

Carboxymethyl cellulose (Low Molecular weight, Sigma) was used as a viscous composition to prepare the microstructure. 2.7 g of CMC (Carboxymethyl cellulose) was dissolved in 30 ml of tertiary distilled water to prepare a 9% (w / v) viscous composition solution. 300 μm in diameter, 700 μm between centers of neighboring contact protrusions, lifting support with a number of contact protrusions 10 × 10 (100 / 6.6 mm 2) and 500 μm in diameter of holes, 700 μm between centers of adjacent holes , It was fixed in the center of the hole of the solid substrate (Stainless steel) having a thickness of 100㎛. At this time, the contact protrusion was raised 0.2mm above the hole of the substrate (Fig. 10-a). Then, the drug-free CMC solution was evenly and thinly applied on the substrate.

In the case of Example VI, a short microstructure having an effective length of 300 mu m was produced. This is to apply to the microneedle patch for cosmetics, and because the viscous composition is loaded with functional cosmetic materials which are relatively inexpensive compared to protein drugs, the viscous composition is not sprayed onto the substrate holes in step (b) of FIG. And thinly applied over the substrate as a whole.

The lifting support was lifted at a rate of 0.4 mm / min for 1 minute and then strongly blown for 5 minutes to solidify the viscous composition below the substrate in a state of being attached to the contact protrusion, thereby strongly binding to the contact protrusion. Then, with strong blowing, descending quickly at a speed of 7.0 mm / min for 10 seconds, and lifting was stopped and then strongly blown for 2 minutes. Finally, blow down strongly for 2 minutes at a speed of 0.1mm / min. (Fig. 10-c, d)

As the moisture dries, the chitosan was cured from the lifting support to the substrate to form a microneedle. After solidifying all the CMC viscous material with strong blowing, the lifting support is momentarily pushed down to cut the middle part of the micro structure with small diameter (Fig. 10-e). 300 micrometers of microneedles were produced.

In the final step, the tacky patch was attached to the completed microneedle base and separated from the substrate (Fig. 10-f, g).

Example Ⅶ

Example VII is the same as the manufacturing method of the top-down microstructure of Example VI except that the carboxymethyl cellulose (Low Molecular weight, Sigma) containing a fat-soluble component and microparticles to be.

A water-soluble vitamin C derivative (Ascorbic acid: Sigma) is mixed with water as a solvent, and retinol (Sigma), a fat-soluble vitamin A derivative dissolved in dichloromethane (Sigma), an organic solvent, is mixed with a homogenizer. Emulsified into oil-in-water (O / W) type at rpm stirring speed.

3 g of carboxymethyl cellulose was dissolved in 30 ml of tertiary distilled water emulsified with vitamin C derivatives and vitamin A derivatives to prepare a 9% (w / v) viscous composition solution. In addition, biodegradable polylactic acid (PLA, Sigma) mycoroparticles are prepared by a multi-emulsion method to include calcein reagent (Sigma), and only microparticles having a diameter of 5 micrometers or less are filtered through a filter (Millex). Then, the prepared microparticles are mixed with carboxymethyl cellulose, resulting in the base material contained in the carboxymethyl cellulose with microparticles loaded with calcein reagent.

300 μm in diameter, 700 μm between centers of neighboring contact protrusions, lifting support with a number of contact protrusions 10 × 10 (100 / 6.6 mm 2) and 500 μm in diameter of holes, 700 μm between centers of adjacent holes , It was fixed in the center of the hole of the solid substrate (Stainless steel) having a thickness of 100㎛. At this time, the contact protrusion was raised 0.2mm above the hole of the substrate (Fig. 3-a). Then, a carboxymethyl cellulose based material containing microparticles was evenly applied on the substrate and thinly applied.

The lifting support was lifted at a rate of 0.4 mm / min for 1 minute and then strongly blown for 5 minutes to solidify the viscous composition below the substrate in a state of being attached to the contact protrusion, thereby strongly binding to the contact protrusion. Then, with strong blowing, descending quickly at a rate of 7.0 mm / min for 10 seconds, and lifting was stopped and then strongly blown for 2 minutes. Finally, blow down strongly for 2 minutes at a speed of 0.1mm / min. (Fig. 6-c, d)

As the moisture dries, the chitosan was cured from the lifting support to the substrate to form a microneedle. After coagulating all of the carboxymethyl cellulose base material with strong blowing, the instantaneous force of the lifting support is lowered to cut off the center of the microstructure having a small diameter (Fig. 6-e). An effective length of 300 ㎛ water-soluble drug, a fat-soluble drug, a microneedle capable of mounting multiple drugs including microparticles was prepared [Fig. 11 a].

In the final step, the adhesive patch was attached to the completed microneedle base part and separated from the substrate (Fig. 6-f, g).

The concentration of the carboxymethyl cellulose-based material depends on the degree of emulsion and the content of microparticles, and the higher the content of the fat-soluble drug, the higher the microparticle content, the lower the concentration of the carboxymethyl cellulose-based material.

Example Ⅷ

Example VII is the same as the manufacturing method of the bottom-up microstructure of Example II, the difference is that the microparticles contained in the carboxymethyl cellulose (Carboxymethyl cellulose, Low Molecular weight, Sigma) as a viscous composition used in the microstructure.

Carboxymethylcellulose (Low viscosity, Sigma) was used as a viscous composition (21) to prepare a microstructure. 3.5 mg of carboxymethylcellulose is dissolved in 30 ml of tertiary distilled water in which vitamin C derivatives and vitamin A derivatives are emulsified to form a 10% (w / v) viscous solution. In addition, biodegradable polylactic acid (PLA, Sigma) mycoroparticles are prepared by a multi-emulsion method to include calcein reagent (Sigma), and only microparticles having a diameter of 5 micrometers or less are filtered through a filter (Millex). Then, the prepared microparticles are mixed with carboxymethyl cellulose, and as a result, the microparticles loaded with the calcein reagent produce a base material contained in carboxymethyl cellulose mixed with cy5.5 reagent. After loading 10% carboxymethyl cellulose on the substrate 20, a carboxymethyl cellulose based material including microparticles is subsequently coated on the substrate by blowing. After dispensing the carboxymethyl cellulose based material containing the microparticles in the desired position (Fig. 2c), through the blowing to form a structure consisting of a viscous composition (d). After dispensing the drug-containing viscous composition on the structure (FIG. 2 e), the lifting support 10 having a 3 × 3 contact protrusion having a diameter of 500 μm was contacted (FIG. 2 f). After 10 seconds of contact with the lifting support, the lifting support was lifted for 10 to 60 seconds (total lifting height: 716.7 μm) at a rate of 5 to 50 μm / s to form the intermediate structure 30 (FIG. 2 g). . It can be seen that the shape of the microneedle structure changes with the speed and time of lifting. Lifting speed is faster than 50 ㎛ / s, lifting for 10 seconds or more, the intermediate structure is not formed and the bond between the carboxymethyl cellulose and the contact protrusion is broken, so the lifting speed is dependent on the kind and concentration (viscosity) of the material Changes should be made accordingly. The moisture of the carboxymethylcellulose was dried while maintaining the blowing air 22 after the lifting (Fig. 2g). As the moisture dried, the carboxymethyl cellulose was hardened from the lifting support to the substrate to form a microneedle (h of FIG. 2). The hardened solid microneedle is cut off by lifting the support at high speed. As a result, a microneedle containing a water-soluble drug, a fat-soluble drug, and microparticles having a diameter of 10 to 80 μm and an effective length of 500 to 3,000 μm was prepared (FIG. 11A). At this time, the diameter of the microneedle can be adjusted by changing the diameter of the contact protrusion. In addition, it was confirmed that changing the concentration (viscosity) of the carboxymethyl cellulose changes the shape of the solid microneedle formed. That is, as the concentration (viscosity) of the carboxymethyl cellulose was higher, the amount of the carboxymethyl cellulose contained in the same amount of the viscous solution was increased, so that the diameter of the microneedles was increased as a whole. The concentration of the carboxymethyl cellulose-based material depends on the degree of emulsion and the content of microparticles, and the higher the content of the fat-soluble drug, the higher the microparticle content, the lower the concentration of the carboxymethyl cellulose-based material.

As described in the above embodiment, in order to manufacture a solid microstructure having desired characteristics (eg, effective length, upper diameter and hardness), the moving speed of the lifting support, the diameter of the contact protrusion, the viscosity of the viscous composition, the strength of the blowing, etc. It can be seen that this is related to the diameter of the microstructure (see FIG. 19).

Once the speed of the lifting support is changed, the speed of the lifting support is increased while the other factors (diameter of the contact protrusion, viscosity of the viscous composition, length of the microstructure, and intensity of blowing) are fixed. It was confirmed that the diameter is made small. However, the difference between bottom-up and top-down is that the bottom of the microstructure is made relatively smaller than the bottom-up manufacturing method, and the diameter of the bottom is similarly produced regardless of the rising speed. (In the case of bottom-up, the diameter of the lower end of the microstructure is proportional to the amount of the viscous composition injected by the dispenser.) [Fig. 19-a to f]

In addition, the diameter of the contact protrusion, the viscosity of the viscous composition, the length of the microstructure, the elements of the speed of the lifting support is fixed and the shape of the microstructure according to the wind speed showed a similar pattern to the change of the lifting support.

19-g ~ j]

However, the change in diameter of the upper end of the microstructure according to the change in the size of the wind velocity was less effective than the change in the diameter of the upper end according to the size of the speed of the lifting support. In other words, the length of the upper end diameter decreases as the speed of the lifting support is increased by 2 times and 3 times.

In addition, when fabricating a microstructure of a certain length without the air blowing, it is confirmed that the production can be produced only by slowing down (0.05mm / min or less) of the lifting support as compared with the case of the air blowing, and the production time also takes more than 3 hours.

In addition, when the rising and falling speed of the lifting support is kept constant, the longer the effective length of the produced microstructure, the greater the possibility that the intermediate structure is not solidified and cut during fabrication.

While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the scope of the present invention. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.

<Description of the code | symbol about the principal part of FIGS. 3 and 4>
20: substrate 21: viscous composition
22: viscous composition containing drug 23: blowing
24: solution dispenser 30: intermediate structure
31: microstructure

Claims

A method of making a solid microstructure, comprising the following steps:
(a) preparing a viscous composition on a substrate;
(b) contacting the contact projection of the lifting support with the viscous composition;
(b-2) lifting the lifting support;
(c) blowing the viscous composition to condense and solidify the viscous composition; And
(d) cutting the resultant of step (c) to form a solid microstructure.

The method of claim 1 wherein the method is carried out under non-heating treatment.

The method of claim 1, wherein the viscous composition comprises a biocompatible or biodegradable material.

The method of claim 1, wherein the viscous composition is hyaluronic acid and salts thereof, polyvinylpyrrolidone, cellulose polymer, dextran, gelatin, glycerin, polyethylene glycol, polysorbate, propylene glycol, povidone, carbomer carbomer, gum ghatti, guar gum, glucomannan, glucosamine, dammer resin, rennet casein, locust bean gum, microfibrillated cellulose, silium Psyllium seed gum, xanthan gum, arabino galactan, arabino galactan, arabic gum, alginic acid, gelatin, gellan gum, carrageenan, karaya gum, curdlan, chitosan , Chitin, tara gum, tamarind gum, tragacanth gum, percelleran, pectin and pullulan Characterized by containing a viscous material Manufacturing method.

The method of claim 4, wherein the cellulose polymer is selected from the group consisting of hydroxypropyl methylcellulose, hydroxyethyl cellulose, ethyl hydroxyethyl cellulose, hydroxypropyl cellulose, alkyl cellulose and carboxymethyl cellulose. .

The method of claim 5, wherein the cellulose polymer is hydroxypropyl methylcellulose or carboxymethylcellulose.

The method of claim 1 wherein the lifting support comprises one or more blowing holes.

8. The method of claim 7, wherein the blowing is through a tuyere of the lifting support.

delete

The method of claim 1, wherein the lifting support is lifted to a height of 1/100 to 80/100 of the length of the finally produced microstructure.

The method according to claim 1, wherein the lifting of the lifting support is carried out simultaneously with blowing to the viscous composition.

The method of claim 1, wherein the blowing in step (c) is performed after the lifting of step (b-2) is completed.

The method according to claim 1, wherein step (b-2) and step (c) are carried out alternately alternately.

The method of claim 1, wherein the microstructure is a microneedle, microspike, microblade, microknife, microfiber, microprobe, microbarb, microarray, or microelectrode.

15. The method of claim 14, wherein said microstructures are microneedle.

The method of claim 1, wherein the viscous composition further comprises a drug or energy.

The method of claim 1, wherein the step (a) comprises applying a viscous composition on a substrate and then spotting the viscous composition and forming a base structure.

18. The method of claim 17, wherein step (b) is performed by contacting a contacting projection of a lifting support to a viscous composition spotted on the base structure.

The method of claim 1 wherein said lifting is carried out from the bottom up.

The method of claim 1 wherein said lifting is performed in a directed manner.

22. The substrate of claim 21, wherein the substrate has an opening, and steps (a) and (b) (i) insert a contact protrusion of the lifting support into the opening of the substrate to which the viscous composition is applied to contact the viscous composition. Or (ii) contacting the lifting support with the viscous composition by inserting the contact support of the lifting support into the opening of the substrate to which the viscous composition has not been applied, and then applying the viscous composition to the opening of the substrate or the entire substrate. Characterized in that the method.

The method of claim 22, wherein the step (c) is performed by condensation and solidification of the viscous composition by blowing on the viscous composition and lowering the contact projection.

A solid microstructure manufactured according to the method of any one of claims 1 to 8 and 10 to 23.

A method of making a solid microstructure, comprising the following steps:
(a) applying a viscous composition on a substrate to form a base structure, and then spotting the viscous composition on the base structure to prepare a viscous composition on the substrate;
(b) contacting the contacting projection of the lifting support with the spotted viscous composition;
(c) blowing the viscous composition to condensation and solidification of the viscous composition; And
(d) cutting the resultant of step (c) to form a solid microstructure.

27. The method of claim 25, wherein the spotted viscous composition comprises a drug.

26. The method of claim 25, wherein the base structure is formed by applying a viscous composition on the substrate or by applying the viscous composition on the substrate and then blowing the viscous composition to the base composition.

27. The method of claim 25, wherein the spotted viscous composition is blown to the spotted viscous composition during the process of spotting the viscous composition on the base structure or after spotting the viscous composition on the base structure.

26. The method of claim 25, wherein the blowing in step (c) is performed while lifting the lifting support, or after the lifting is completed, or the blowing and lifting are performed discontinuously alternately.

30. The method according to claim 29, wherein the blowing in step (c) is carried out after the first lifting is completed and then the blowing is carried out simultaneously with the second lifting.

delete

A method of making a solid microstructure, comprising the following steps:
(a) contacting the viscous composition by (i) inserting the contact projection of the lifting support into the opening of the substrate coated with the viscous composition, or (ii) inserting the contact projection of the lifting support into the opening of the substrate not coated with the viscous composition. Then contacting the viscous composition with the contact projection of the lifting support by applying the viscous composition to the opening of the substrate or the entire substrate;
(b) condensing and solidifying the viscous composition by blowing on the viscous composition and lowering the contact protrusion or by lowering the contact protrusion and then blowing on the viscous composition; And
(c) cutting the resultant of step (b) to form a solid microstructure.

33. The method of claim 32, wherein said viscous composition contains a drug.

33. The method according to claim 32, wherein step (a) inserts the contact projection of the lifting support into the opening of the substrate to which the viscous composition has not been applied, and then applies the viscous composition to the opening of the substrate to apply the contact projection of the lifting support to the viscous composition. And is carried out by contact.

delete

33. The method of claim 32, further comprising the step (bc) of applying a viscous composition on the substrate between steps (b) and (c).

41. The method of claim 40, wherein the viscous composition applied on the substrate is solidified by blowing.

delete

33. The method of claim 32, further comprising, after step (c), step (d) attaching a tacky patch on the substrate and then separating the solid microstructure with the tacky patch attached from the substrate. How to.

delete